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ABSTRACT 
The objective of the study was to develop a computerized reminder system to 
ensure that preoperative deep vein thrombosis (DVT) prophylaxis (anticoagulation or 
compression devices) was provided for eligible patients. The study design was a 
prospective trial with historic controls. The setting was LDS Hospital in Salt Lake City, 
Utah, a tertiary care teaching center. The alternate hypothesis stated that a conlputerized 
renlinder system would increase the rate of DVT prophylaxis in surgical patients. A local 
consensus was developed among surgeons as to which procedures should receive DVT 
prophylaxis. The historic rate of DVT prophylaxis was measured for these procedures at 
83.8% (794 of 948 eligible cases). A computerized reminder system was implemented on 
the hospital's computer system, which flagged patients scheduled for a procedure for 
which DVT prophylaxis was indicated. The rate of DVT prophylaxis was then 
remeasured. For the 3 months after the introduction of the reminder, compliance with 
DVT prophylaxis rose to 99.3% (1118 out of 1126 eligible cases). Fourteen of 54 types 
of procedures showed statistically significant improvement in the rate of DVT 
prophylaxis between the study group and the historic controls. The procedures which did 
not show inlprovement had a small number of cases (n<8) or else were already at a high 
level of prophylaxis (prophylaxis rate>90%). When individual procedures were 
combined into groups of similar surgeries, 7 of 10 groups showed statistically significant 
improvement. Similarly, 3 of 4 surgical divisions showed statistically significant 
improvement. For all cases combined, the rate of DVT prophylaxis showed highly 
significant improvement (p<.OOl) between the historic controls (83.80/0) and the study 
group (99.30/0). The conclusion of the study was that a computerized reminder appeared 
to be an effective method of increasing the rate of DVT prophylaxis in surgical patients. 
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1. INTRODUCTION 
Purpose of Study 
The purpose of the study was to use the relatively new discipline of medical 
informatics to solve an old problem-preventing thromboembolism in surgical patients. 
Surgery of any type is not without risks and complications. Postsurgical thromboembolic 
disease, presenting as either deep vein thrombosis or pulmonary embolism, can be an 
unintended yet devastating byproduct of surgery. As the old aphorism states, an ounce of 
prevention is worth a pound of cure, and prophylaxis of thromboembolism is vital for 
certain surgical procedures. The study's goal was to develop a computerized reminder 
system to ensure that appropriate preoperative prophylaxis was ordered for eligible 
patients. 
The Problem of Venous Thromboembolism 
Venous thromboembolism is the abnormal presence of stationary blood clots 
(thrombus) or free floating clots (embolism) in the veins. When the blood clot occurs in 
the major named veins, the disease is referred to as deep vein thrombosis (DVT). If a 
blood clot breaks free, it may travel through the venous system to the heart and then 
impact in the lungs, causing the serious disease known as pulmonary embolism (PE). 
The initial thrombus is caused by 1 or more of 3 factors - circulatory stasis, 
endothelial injury, and abnormal coagulation - which together are known as Virchow's 
triad (1). During a surgical procedure, patients are placed at risk of venous thrombosis. 
General anesthetic causes vessels to dilate and circulation to slow, leading to stasis. The 
veins themselves may be directly damaged, either through trauma preceding the surgery 
or injury during the surgical procedure. Finally, surgical patients may be hypercoaguble 
from medications or disease processes such as cancer. 
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Deep vein thrombosis may be asymptomatic or the patient can develop local 
problems in the lower limbs, such as varicose veins and skin ulcers. More serious 
complications arise if the thrombus progresses to an embolus; i.e., the clot breaks free 
from the leg and travels through the heart to the lungs, causing a pulmonary embolism. A 
PE may impede the flow of blood to the lungs and cause difficulties with oxygenation. 
Whereas some cases of PE may be asymptomatic, others present more dramatically and 
require hospitalization and anticoagulant therapy. Unfortunately, in many cases the initial 
presentation of a PE is sudden death (2-4). 
Not surprisingly, venous thromboembolism has been extensively examined in the 
medical literature. DVT and PE have been studied in different populations, such as the 
elderly, cancer patients, trauma victims and surgical patients (5-18). A recurrent theme in 
many studies is that the diagnosis is often missed and the consequences can be fatal (19-
21 ). 
In the recent Fourth American College of Chest Physicians (ACCP) Consensus 
Conference on Antithrombotic Therapy (2), the magnitude of the problen1 was outlined. 
Puln10nary embolism causes the death of 100,000 patients each year in the United States 
(22). Fatal PE may be the most common preventable cause of hospital death (23). Yet, 
despite the proven efficacy of prevention, prophylaxis for deep thrOlnboembolism is 
underutilized and in one study of 2,000 patients with multiple risk factors for 
thromboembolism, only one third received prophylaxis (24). 
Prevention of Venous Thromboerrlbolism 
When properly used, prophylaxis can substantially reduce the incidence of 
thromboembolic disease in the surgical patient. Prevention of DVT has been extensively 
studied for decades, with prophylaxis in most studies consisting of sequential 
compression devices (SCDs) or anticoagulant therapy. SCDs are inflatable stockings 
wrapped around the leg during surgery. At regular intervals they fill with air and then 
empty. The legs are squeezed when the stockings fill, which promotes venous 
circulation. SCDs are also referred to as intermittent pneumatic compression stockings 
(lPCs), or they may be known by a trade name, such as Plexipulse. 
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Low dose unfractionated heparin (LDUH) and coumadin are anticoagulants which 
interfere with the normal coagulation pathways, resulting in decreased clot formation. 
Recently, low molecular weight heparin (LMWH) has come under increasing scrutiny as 
an anticoagulant which may be as effective as LDUH yet have fewer bleeding 
complications (25-36). With so many studies of different agents, no one regimen has 
proven superior. Recommendations for prophylaxis often list several options (2,37-49). 
For some procedures, such as spinal surgery, investigators have not been able to 
arrive at a consensus for prophylaxis (50). However, for most other types of surgery, the 
incidence of thromboembolism and the need for prophylaxis have been well 
demonstrated. Specific to general surgery, in a meta-analysis of over 50 trials with a total 
of more than 4,000 patients, Clagett and Reisch (51) determined the overall rate of DVT 
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in control patients to be 16 to 300/0. The more serious finding of proximal DVT, which is 
DVT proximal to the popliteal vein, was 70/0; and the rate of fatal pUlmonary embolism 
was 0.9%. In general surgery, prophylaxis through use of anticoagulants reduces the 
relative risk of DVT by up to 80%; compression devices offer similar risk reduction 
(2,3). 
Orthopedic patients can also benefit greatly from DVT prophylaxis (2). Specific to 
elective joint replacement patients, the rate of postoperative DVTs has been measured at 
40 to 800/0. The rate of fatal PE in various studies is reported to be from 0.3 to 60/0 (16-
18,41). Although the exact incidence or mortality is in dispute, there is general agreement 
on the usefulness of preventative measures, which again reduce the rate of DVT by up to 
800/0 compared with nonprophylaxed patients (40). 
Despite the well-known benefits of DVT prevention, several studies have shown 
that prophylaxis for thromboembolism is underutilized (52-56). Several possible reasons 
exist for surgical patients not receiving DVT prophylaxis, including concerns over 
bleeding, thrombocytopenia and the cost of prophylaxis. Fears of major bleeding in post 
operative patients treated with low dose unfractionated heparin or low molecular weight 
heparin are unfounded (25). There may be a slight increased incidence of wound 
hematomas with anticoagulation (26) which can be avoided through use of mechanical 
methods of DVT prophylaxis, such as SCDs. Heparin-induced thrombocytopenia (HIT) 
is uncommon; vascular thrombosis associated with HIT is even more rare (57). The 
economic benefits of DVT prophylaxis have been shown to far outweigh its costs (58,59). 
One final reason that a physician may not order DVT prophylaxis is the subjective 
opinion that DVTs or PEs are not a problem in his or her individual practice, as overt 
5 
cases of thromboembolism are rarely encountered. The answer to such an objection is a 
statistical one, concerning the perception of low frequency events and individual versus 
group experience (60). If a surgeon does 100 major surgeries in a year and orders 
prophylaxis 90% of the time, and 1 % of nonprophylaxed patients suffer a fatal PE, then 
that surgeon will see a fatal PE once every 10 years on average, and only a few times over 
the duration of his or her career. Therefore the impression arises that fatal PE is not a 
common problem, which leads to complacency over ordering prophylaxis. However, if 
all surgeons in a hospital perform several thousand major procedures a year and only 900/0 
of these patients have prophylaxis, there may be 2 or 3 deaths per year from PE. Thus, 
although the individual surgeon will rarely see a fatality from PE, the aggregate data show 
the problem in its true magnitude. Appropriate prophylaxis can reduce the number of PEs 
by up to 800/0 and could therefore conceivably save several lives per year in a large 
surgical center. 
Given that DVT prophylaxis in appropriately selected surgical patients is desirable 
and constitutes good medical practice, there are 3 reasons eligible patients may not 
receive this therapy. The first is an issue of lack of knowledge; some doctors may not be 
aware of the advantages conferred by prophylaxis and so do not order preventative 
n1easures. Incognizance can be ameliorated through physician education (61). A second 
possibility is that the physician orders prophylaxis, but there is a breakdown in the 
process of care, resulting in a nonprophylaxed patient. Berwick (62) has examined the 
problem of quality assurance and described the many stages where physician orders may 
go askew. 
The final reason why prophylaxis may be missed is McDonald's observation that 
all physicians occasionally forget (63). Even the best trained clinicians have a 
measurable rate of omitting to do things that they know they should do. To quote, 
, ..... man is not perfectible. There are limits to man's capabilities as an information 
processor that assures the occurrence of random errors in his activities" (p.13 51). This 
same insight is present in Leape's paper on Error in Medicine (64). 
Attempts to Improve Rates of DVT Prophylaxis 
The medical literature acknowledges the problem with shortcomings in the 
administration of DVT prophylaxis and promotes the benefit that may accrue from wider 
use of prevention. Elliott closed his review of pulmonary embolism with these words: 
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"The consistent application of efficacious prophylactic methods to all patients at risk may 
be the greatest advance in the management of venous thromboembolism in the coming 
years" (2, p.72). 
Few papers address the problem of increasing the use of DVT prophylaxis. 
Attempted methods to improve prophylaxis include local consensus conferences and 
frequent reinforcement to junior house staff, as well as manual reminder systems and 
feedback to physicians (65). 
A Danish study looked at rates of DVT prophylaxis for surgery from 1981 to 
1990. It found that the rate of prophylaxis increased from 500/0 to 68% over this interval. 
The authors speculate that the increase may be due to mandatory theoretical surgical 
education, in place in Dennlark since 1987 (66). 
A pair of British studies also looked at changing rates in DVT prophylaxis in 
elective surgery (53,67). The first study, in 1994, reported a prophylaxis rate of 850/0. 
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The authors then instituted a program which consisted of education of junior residents 
(who write most of the orders) and a preoperative checklist, used by the nursing staff. In 
the follow up study 1 year later, the rate of prophylaxis had increased to 97 0/0. It is 
important to note the limits of the study - only 77 patients were involved and there was no 
statistical analysis. No long-term follow up was done to measure attrition. 
An American study compared 2 different methods of increasing DVT prophylaxis 
to a control group. The study measured the rate of DVT prophylaxis at 290/0 in 15 short 
stay hospitals in 1986. The hospitals were then divided into 3 groups. The control group 
had no interventions. The Continuing Medical Education (CME) group received several 
educational seminars on the importance of DVT prophylaxis. The Quality Assurance 
(QA) group received the same education as the CME group, plus individual surgeons 
were sent letters informing them of their personal rate of prophylaxis and how they 
compared to their peers. In 1989, the rate of DVT prophylaxis was measured again. The 
control group prophylaxis rate increased to 510/0; the CME group increased to 490/0; and 
the QA group increased to 550/0. The authors concluded that even after extensive 
CME/QA interventions, prophylaxis for venous thrOlnboembolism remained 
underutilized, and suggested that new approaches to changing clinical practice be 
developed (68). 
The 3 studies cited above demonstrate that increasing DVT prophylaxis is not a 
simple nlatter. Education, manual reminders and physician feedback appear insufficient 
to increase and sustain the use ofDVT prophylaxis. Is there a better strategy? Leape's 
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paper on Error in Medicine suggests standardization and reduction of reliance on memory 
(64). In his oft-quoted seminal 1976 paper, McDonald is even more specific when he 
concludes" ... though the individual physician is not perfectible, the system of care is, 
and ... the computer will playa major part in the perfection of future care systems" (63, 
p.1355). Like the proverbial elephant, the computer never forgets. Despite the potential 
of this tool, a review of the literature through a Medline search failed to find any studies 
which used computer generated reminders to increase DVT prophylaxis. 
Computerized Reminders 
A powerful clinical application in medical informatics is the use of computer 
generated reminders and alerts. Rind et al. defined a reminder as "a communication that 
is sent to a clinician around the time of patient contact," whereas an alert is a 
communication ..... sent to a clinician as soon as the conditions that prompt the generation 
of the alert are known to have occurred" (69, p.122). Numerous studies have 
demonstrated the efficacy of computer reminder and alert systems, for both outpatient and 
inpatient use (70-84). A recent meta-analysis by Shea et al. of 16 randomized controlled 
trials showed the effectiveness of computer-based clinical reminder systems for 
preventive care in the ambulatory setting (85). 
For over 20 years, the LDS Hospital in Salt Lake City has had a clinical 
cOlnputing system known by the acronym HELP (Health Evaluation through Logical 
Processing) (86-91). The HELP system has successfully integrated information 
n1anagement and clinical medicine, including several applications of alerts and reminders. 
These programs have been of use in preventing adverse drug effects and administering 
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preoperative antibiotics. The authors of these projects have been able to show changes in 
process outcomes, clinical outcomes and substantial cost savings (92-96). 
One innovative project at LDS Hospital has been the antibiotic reminder program 
for surgical patients. Introduced over a decade ago, the antibiotic reminder program 
automatically screened surgical patients and flagged those who were to receive 
perioperative antibiotics. Originally a sticker was placed on the patient's chart; the 
sticker was soon superseded by a printed reminder on the operating room (OR) schedule. 
With this computerized reminder in place, the rate of perioperative antibiotic use in 
appropriate procedures increased from 40% in 1988 to 99.1 % in 1994. Postoperative 
wound infections decreased from 2% to 0.40/0 during the same period (92,93,97-99). 
Computers can generate reminders and alerts in 2 different ways. In event-driven 
programs, the user inputs some or all of the necessary data, and then receives consultative 
output. For example, in the diagnostic program Iliad, the user enters the patient's 
sympton1s, physical findings and laboratory results. The program responds with a list of 
differential diagnoses and relative probabilities. If the user enters more information, the 
list and probabilities may change. The 'event' is the user entering data (100). 
In data-driven programs, the user remains passive and is prompted by the system 
whenever a set of criteria is met. The components of a data-driven system usually include 
the clinical data, an expert system to monitor the database, and a knowledge base with 
rules of logic that trigger the reminder (101). The reminder itself may be a message for 
the physician during the next sign-on to the hospital's information system, a message on 
the physician's pager, or a note placed in the chart by nursing or clerical staff. An 
example of a data-driven system is the antibiotic ren1inder at LDS Hospital, discussed 
above. The primary advantage of the data-driven method is that the reminders are 
generated automatically, satisfying Leape's criteria of standardization and reduced 
reliance on memory. 
Outline of Remainder of Thesis 
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The remainder of the thesis will describe in detail the Methods and Results of a 
study conducted at LDS Hospital. The study measured the baseline rate of DVT 
prophylaxis at the hospital and then remeasured the rate after implementation of a 
computerized reminder. The Methods and Results sections are followed by a Discussion 
section which addresses the Quality Improvement (QI) process, physician guidelines, cost 
issues and limitations of the study. After the Summary and Conclusions, there is a list of 
appendices followed by references cited in the text. 
II. METHODS 
List of Hypotheses 
The purpose of the study was to develop a computerized reminder system to 
ensure that appropriate preoperative DVT prophylaxis was ordered for eligible patients. 
The hypotheses were as follows: 
Ho (null hypothesis) - A computerized reminder system will not affect the rate of 
DVT prophylaxis in surgical patients. 
HI (alternate hypothesis) - A computerized reminder system will affect the rate of 
DVT prophylaxis in surgical patients. 
Setting 
The study was carried out at LDS Hospital in Salt Lake City, Utah. LDS Hospital 
is a facility of Intermountain Health Care (IHC), a health maintenance organization which 
covers approximately 750,000 people in 3 states. LDS Hospital is licensed for 520 beds 
and is an academic teaching center affiliated with the University of Utah. Surgical 
departments and divisions include general surgery, orthopedic surgery, gynecological 
surgery, urological surgery, cardiovascular surgery, thoracic surgery, plastic surgery and 
neurological surgery. There is no elective pediatric surgery at the hospital. The surgeons 
at LDS Hospital perform over 15,000 cases a year. 
The majority of the preliminary work for the study was done July to October 
1997; data gathering took place November 1997 to January 1998; analysis and write up 
were done February to April 1998. 
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Institutional Review Board (lRB) approval for the study was obtained from both 
LDS Hospital and the University of Utah and was filed with the Graduate Records Office 
at the University of Utah. 
Study Design 
The study was a pre- and postmeasurement of compliance in a study group 
compared to historic controls. The study methodology was based on the quality 
improvement (QI) work of Berwick (62,102-105) and Williamson (106-109), as well as 
the steps in the continuous quality improvement (eQI) approach as practiced by 
Kuperman, James, Jacobsen and Gardner at LDS Hospital (110). The major steps in the 
study were to evaluate the baseline rate of DVT prophylaxis, assess any Achievable 
Benefit Not Achieved (ABNA), plan for a change in work patterns, implement the 
change, and then reevaluate. 
The concept of ABNA deserves further comment. ABNA is the difference 
between the results achieved with the current standard of practice, and the best results that 
are possible to achieve under real circumstances. For example, clinical outcome after 
myocardial infarction is known to be related to the time between patient presentation in 
the emergency department and the time of treatment with thrombolytics (111,112). If the 
best emergency wards in the country take an average of 10 minutes to administer 
thrombolytics to heart attack patients, and Hospital XYZ takes 11 n1inutes for the same 
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task, not much ABNA exists. If, however, Hospital XYZ takes 45 minutes to administer 
thrombolytics, then considerable room for improvement (ABNA) exists. 
Congruent to the concept of ABNA is the Minimal (or Maximum) Acceptable 
Standard (MAS). The MAS is the specific goal set to eliminate ABNA. For example, a 
surgical department may have a postoperative wound dehiscence rate of 5% for major 
abdominal procedures. The surgeons in the department know that the average rate of 
dehiscence is 3%. They set a goal for their department of 2.5% - this rate becomes their 
MAS for wound dehiscence. If they succeed in achieving their goal, they would have 
eliminated the ABNA. 
Description of Patient Population 
All patients scheduled for a procedure which qualified for DVT prophylaxis, as 
determined by the participating surgeons, were included in the study. There were no 
pediatric patients (age less than 16) in the study. Both elective and emergency cases were 
included in the study. Consent for participation in the study was not obtained from 
individual patients as DVT prophylaxis is considered a routine part of surgical care and 
the patients were not exposed to new drugs or devices. 
Description of Hospital Staff Involved 
Letters announcing the project were sent out to all divisions of surgery by Dr. 
Greg Elliott, a pulmonary physician at LOS Hospital who was well known for his work 
with venous throl11boembolism. Dr. Elliott was an advisor to the author and a n1ember of 
the graduate comn1i ttee that judged the thesis. A copy of the text in the letter is in 
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Appendix A. The divisions of general surgery, orthopedic surgery, gynecological surgery 
and urologic surgery agreed to join the study. The divisions of plastic surgery, thoracic 
surgery and neurologic surgery did not reply or declined participation. 
Hospital staff other than surgeons were also involved in the study. The nurses in 
the short stay (same-day admission) unit, the orthopedic unit, and the OR played an 
important role in the study, as described below. In addition, the surgical staff who 
assemble the case carts participated in the study. One of the hospital's programmers, 
Kyle Johnson, wrote one program for the study and helped debug another. Numerous 
individuals from the Department of Medical Informatics gave advice and direction when 
needed. 
Determining Baseline DVT Prophylaxis Rates 
The initial step in the study was to determine the baseline rate of DVT 
prophylaxis and decide if there was any room for improvement, or ABNA. The baseline 
rate was expressed as the ratio of the number patients receiving prophylaxis over the 
number of patients requiring prophylaxis. If the baseline rate of DVT prophylaxis 
approached 1000/0, then it would not be necessary to embark on an effort to increase the 
rate. 
Logically, it may be assumed that the most straightforward method to measure the 
baseline rate of DVT prophylaxis in historic controls would be to directly query the 
patient database at LDS Hospital. However, different types of data are stored in different 
locations using different coding systems. The process used to measure the rate of 
prophylaxis in historic controls is explained in this section. 
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Patient data at the LOS Hospital are stored on the HELP (Health Evaluation 
through Logical Processing) system as PTXT (Pointer-to-Text) codes. The HELP system 
contains 3 patient databases. The current database contains information on inpatients 
from time of admission up to 10 days postdischarge. The short-term archive has 
information on patients from time of discharge to 6 months postdischarge. The long-term 
archive is the repository of all patient information back to 1983. 
Information germane to this study stored in the HELP system would include the 
primary surgical procedure, any medications given and the use of SCOs. In the 
hierarchical PTXT coding system, the first digit is the data class. Scheduled procedures 
are data class 38. All scheduled procedures begin with the number 38, and all patients 
scheduled for surgery will have a PTXT code beginning with 38 in their electronic 
clinical record. The third digit is the field code, which will vary by department of 
surgery. For example, orthopedic surgery is field code 18. A star represents a wild card 
character. Thus, the PTXT code 38. * .18. *. * indicates a scheduled orthopedic procedure. 
The specific procedure is defined by the content in place of the wild cards. For example, 
a scheduled total hip replacement is coded in PTXT as 38.1.18.1.78. Once the procedure 
has been completed, the data class is changed to 24, i.e., a completed hip replacement is 
coded as 24.1.18.1. 78. The third and fifth digits alone may also be used to represent the 
procedure~ thus an alternate of writing the PTXT code for a hip replacement is 18.78. 
PTXT codes also exist for prescribed drugs. However, for each medication it was 
necessary to refine the list of PTXT codes. For example, when searching for PTXT codes 
under' heparin' in the cross reference feature of HELP, over 40 different codes were 
matched. S0l11e of these codes were for heparin-coated devices, or a Ininuscule dosage of 
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heparin to 'hep-Iock' an intravenous (IV) site, a standard nursing practice to prevent a 
blood clot from blocking the line. These uses of heparin obviously do not constitute 
perioperative venous thromboembolic prophylaxis and their inclusion in the study would 
be misleading. Only 2 heparin PTXT codes were included in the study as these the 2 
forms of heparin are used for DVT prophylaxis - heparin injection subcutaneous 
(8.1.8.2.3.10.0.0) and low molecular weight heparin (8.1.8.2.3.152.0.0). Coumadin, 
which is used for DVT prophylaxis in total joint replacement patients, has the PTXT code 
8.1.8.2.1.1.0.0 and was also included in the study. 
Similar to the PTXT procedure codes, the data class of the PTXT code for a 
medication changes once the medication has been taken by the patient from data class 8 
to data class 48. For example, when a physician prescribes coumadin, the PTXT code for 
the prescribed medication in the HELP system was 8.1.8.2.1.1.0.0. Once the patient has 
taken coumadin, the PTXT code became 48.1.8.2.1.1.0.0. 
Sequential compression devices (SCDs) and Plexipulse boots (a type of SCD) are 
coded in the same manner. The PTXT codes used in the study to determine DVT 
prophylaxis were SCD leg wrap (46.1.11.2.14.105.0.0), SCD foot wrap 
(46.1.11.2.14.110.0.0) and Plexipulse boots (112.1.33.3.50.30.35.0). 
Each PTXT code for medications and mechanical devices has a corresponding 
charge code listed in the AS400 computer, which the hospital uses for financial and 
billing purposes. When a PTXT code for a medication or other device is entered into the 
HELP system, a charge code for the item is captured in the AS400 financial system. The 
forms of DVT prophylaxis along with their corresponding PTXT codes and charge codes 
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are shown in Table 1. The relationship between the HELP system and the AS400 system 
is shown in Figure 1. 
The patient's electronic record consists of clinical information, including surgical 
procedures and medications, coded as PTXT codes. The ideal method of measuring the 
baseline rate of DVT prophylaxis would be to query the HELP long-term archive for 
PTXT codes for surgical procedures where prophylaxis is indicated, and then search those 
patient records for the PTXT codes listed in the table above. However, information in the 
financial system (the AS400) does not always form part of the electronic clinical record. 
For example, SCDs which are used only at the time of surgery are not coded into the 
electronic clinical record, although later on they may be coded into the record if the 
patient is admitted to a surgical unit with SCDs in place. A search of the HELP long-term 
archive would not reveal all cases where SCDs were used for short stay procedures. 
Fortunately, another method existed to measure baseline DVT prophylaxis. Data 
from both the HELP system (procedure codes) and the AS400 (charge codes for 
medications and SCDs) are archived in IHC's Enterprise Data Warehouse (EDW) in an 
Oracle relational database. The procedure codes and charge codes are stored in 2 different 
tables - the Patient Encounter Summary table and the Hospital Encounter Transaction 
Table 1. Forms of DVT prophylaxis with their PTXT codes and charge codes. 
Item PTXT code Charge code 
heparin injection 8.1.8.2.3.10.0.0 7642762 
LMWH 8.1.8.2.3.152.0.0 7636418 
coumadin 8.1.8.2.1.1.0.0 7671449 
SCD leg wrap 46.1.11.2.14.105.0.0 784207 
SCD foot wrap 46.1.1l.2.14.110.0.0 788109 
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Figure 1. Relationship between the HELP system and other hospital systems. The 
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AS400 financial system is shown in the diagram. PTXT codes carrying a financial charge 
that are entered into the HELP system will also appear in the AS400 as charge codes. 
However, a charge code entered directly into the AS400 does not necessarily appear as a 
PTXT code in the HELP system. 
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table. The 2 tables have a common field in the Encounter ID. By using Standard Query 
Language (SQL) statements, it was possible to query the EDW database for patients who 
had specified procedures, and determine how many of those patients had received DVT 
prophylaxis in terms of an anticoagulant (heparin, low molecular weight heparin, or 
coumadin) or SCDs by checking the charge codes. 
Procedure codes in the EDW are stored as ICD9 codes, not PTXT codes. Each 
PTXT procedure code has a corresponding code in the International Classification of 
Disease, 9th edition (ICD9), Volume 3. For exanlple, a total hip replacement has a PTXT 
code of24.1.18.1.78 (or 18.78); the equivalent ICD9 code is 81.51. The 2 coding 
systems have been mapped to each other in the cross reference feature of the HELP 
system. 
To restate: the PTXT codes are stored in the HELP patient databases. The ICD9 
codes for the same procedures are not stored in HELP; rather, they are stored in the 
Oracle database of IHC's Enterprise Data Warehouse. Conversions of codes from the 
PTXT format to the ICD9 format occurs as data are moved from the HELP and AS400 
systems to the Casemix files stored in the EDW. The search of the EDW to measure 
baseline prophylaxis rates used ICD9 procedure codes, not PTXT codes. 
An initial list of procedures which qualify for DVT prophylaxis was composed by 
the author. The list contained common procedures for which DVT prophylaxis was 
widely accepted. (The list was later expanded after meeting with various divisions of the 
Department of Surgery at LOS Hospital - see below.) The full list is contained in 
Appendix B. The list included major abdominal surgery, breast cancer surgery, endocrine 
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surgery, total joint replacement surgery, major orthopedic trauma, hysterectomies, 
nephrectomies and prostatectomies. 
Of note, a procedure may have n10re than one ICD9 code. For example, there are 
3 ICD9 codes for esophagectomy, as there are 3 different surgical techniques for 
removing the esophagus. Similarly, there are 5 ICD9 codes for gastrectomy, depending 
on which part of the stomach is removed. As these codes represent variations of the same 
procedure, they have been grouped together under a single procedure name when 
appropriate. 
Using the ICD9 procedure codes and the charge codes for anticoagulants and 
SCDs, an initial query of the EDW was done for the year 1996. An example of a SQL 
statement used to query the database is given in Figure 2. The first query determined how 
select distinct 
p.encntr _ id, p.hsptl, p.prcdrl, p.dschrg_ month, p.dschrgyr 
from cm.pt_encntr_smry p, ar.trnsctns t 
where p.encntr _id = t.encntr _id 
and p.hsptl = 128 
and p.dschrg_yr 1996 
and p.prcdrl = '8151' 
order by p.encntr _id; 
select distinct 
p.encntr _id, p.hsptl, p.prcdrl, p.dschrg_yr 
fron1 cm. pt _ encntr _ smry p, ar. trnsctns t 
where p.encntr _ id = t.encntr _ id 
and p.hsptl = 128 
and p.dschrg_yr = 1996 
and t.chrg_cd in (7642762,7671449,7636418,784207,788109,788752) 
and p.prcdrl = '8151' 
order by p.encntr id~ 
Figure 2. Standard Query Language (SQL) statements. These SQL statements were used 
to query the EDW database to measure the baseline rate of DVT prophylaxis in the 
historic controls. 
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many cases of a particular procedure were done at LDS Hospital in 1996. In the example 
below, the procedure is ICD9 code 81.51, total hip replacement. The second query 
determined how many of these cases received D VT prophylaxis. The rate of D VT 
prophylaxis is the result from the second query (number of prophylaxed cases) over the 
result of the first query (nuITlber of cases requiring prophylaxis). 
Results from the query are shown in the table in Appendix B. In summary, DVT 
prophylaxis rates were determined for 40 different procedures. The rate of prophylaxis 
for some procedures was perfect, including 30 out of 30 cases of pancreatic surgery. For 
other procedures, it was near perfect, such as 189 out of 193 hip replacement surgeries, a 
rate of 98%. Any attempt to prove statistical significance in improving such a high rate 
would require large numbers over several years and likely would not have a measurable 
clinical impact. 
There were several procedures for which prophylaxis was well below 1000/0. For 
example, 494 of 562 (88%) of laparoscopic cholecystectomy procedures had prophylaxis, 
leaving 68 patients (120/0 of alliaparoscopic cholecystectomies) uncovered. The issue 
here is not one of disagreement over whether prophylaxis was indicated, as all general 
surgeons would later agree that all 'lap choles' should be covered. As another example, 
prophylaxis for thyroid and parathyroid surgery was only 53% (46 of 86 cases). Overall, 
for the 4 divisions that participated in the study, the 1996 DVT prophylaxis rate for the 
selected procedures was 73.3% (2,474 of 3,375 cases). 
The rate of 73.30/0 suggests that there is considerable room for improvement, or 
Achievable Benefit Not Achieved (ABNA). The results of this initial query were later 
presented to the 4 participating divisions of surgery, along with information from the 
International Cooperative Pulmonary Embolism Registry (lCOPER) study, previously 
conducted at LDS Hospital. 
Data from the lCOPER Study 
The unfortunate sequalae of deep vein thrombosis include pulmonary embolism. 
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PE can have a late presentation, occurring several weeks or months after the operation 
(21). By that time the patient is usually home, which for lHC patients may be in another 
city or even another state. However, at least some of the patients will be readmitted to 
the LDS Hospital, and thus although the exact magnitude of PE cannot be determined, 
some cases can be detected. In 1995 and 1996, the LDS Hospital participated in the 
lCOPER study (113), a study designed to quantify and qualify the disease of pulmonary 
embolism. The ICOPER data was reviewed to see how often a postsurgical PE (defined 
as PE within 2 months of surgery) presented to LDS Hospital, with the rationale that if no 
cases of PE occurred, then there would be no need to increase the rate of DVT 
prophylaxis. 
The LDS ICOPER data showed that in a 18-month period, 27 patients presented 
to LDS Hospital with postoperative PE. Nineteen of these patients had not received any 
form of DVT prophylaxis. Otherwise stated, 700/0 of postsurgical cases of pulmonary 
embolism occurred in patients without prophylaxis and were potentially preventable. A 
summary of the results of the ICOPER study is presented in Appendix C. 
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Developing Consensus on Procedures Requiring DVT Prophylaxis 
The next step was to meet with the participating divisions of surgery at LDS 
Hospital to develop a more specific list of procedures to be covered by DVT prophylaxis. 
The author met with each division separately, reviewed the problems of deep vein 
thrombosis and pulmonary en1bolism, and presented the findings from the initial database 
search and the lCOPER study. 
Recommendations for prophylaxis as per criteria of the American College of 
Chest Physicians (ACCP) were accepted as a guideline to be used in developing the list of 
procedures. The ACCP recommendations were developed after a consensus conference 
in 1995 (2) and are summarized in Appendix D. The key recommendation is that any 
surgery lasting greater than 30 minutes should have DVT prophylaxis. 
Surgical procedure codes form part of the PTXT codes in the HELP system. The 
procedure codes were originally developed for the benefit of the surgical staff who 
assemble the case carts, which are the collections of instruments and materials necessary 
to do the specified surgery. The first PTXT procedure list was organized alphabetically 
by procedure. For example, in general surgery all PTXT codes start with 14. The codes 
14.1, 14.2 and 14.3 represented abdominal perineal resection, ampullary sphincteroplasty 
and anal fistula. The list continued alphabetically to 14.77, which was a ventral hernia 
repair. The list has been modified over the years and new procedures were added to the 
end of the list as they appeared, without trying to retain the alphabetical nature of the list. 
The most recently coded procedure is 14.192, laparoscopic colectomy. 
One or two physician volunteers from each division then met with the author to 
further refine the list of procedures for prophylaxis. For each division, the list of 
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procedures was reviewed, discussed and modified by other members of the division until 
consensus was obtained. {n the case of a disagreement over a particular procedure, the 
procedure was not included in the list and any surgeons wishing prophylaxis for those 
cases could order it at their own discretion. A potential bias was thereby avoided through 
elimination of the situation where surgeons may not order prophylaxis if they disagreed 
with the need for it in a particular procedure. Reaching consensus was most arduous in 
the division of orthopedic surgery, where many procedures were removed from the 
preliminary list, in spite of their satisfying ACCP criteria. 
The final approved list of procedures for DVT prophylaxis is presented as 
Appendix E. Procedures under a general anesthetic which lasted more than 30 minutes 
were usually included in the list of procedures to receive DVT prophylaxis. For example, 
a cholecystectomy will almost always last longer than half an hour and was listed for 
prophylaxis. Open appendectomies usually take less than 30 minutes and were not 
included on the list. 
Intradivision variation existed in the types procedures selected for prophylaxis. 
For example, the general surgeons decided to cover all of their laparoscopic cases, even 
laparoscopic appendectomies which often last less than 30 minutes. Their physiologic 
rational was that increased intraabdominal pressure from the pneumoperitoneum may 
predispose the patient towards thromboen1bolism. By contrast, the gynecologic surgeons 
decided to cover only the laparoscopic cases which usually took greater than 30 minutes. 
They excluded from the study some of their n10re con1mon procedures, such as diagnostic 
laparoscopy and laparoscopic tubal ligation, which ordinarily take less than half an hour 
to complete. 
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Several exceptions were made to the 30 minute rule by the Division of Orthopedic 
Surgery. Shoulder repairs and spinal surgeries may last several hours, yet the division 
could not reach consensus on whether or not these cases should receive DVT prophylaxis. 
These procedures were not included in the study and the decision to use prophylaxis was 
left to the individual surgeon. 
For the method of DVT prophylaxis, the orthopedic surgeons decided that joint 
replacement patients should have anticoagulation in the form of heparin, LMWH, or 
coumadin. The surgeons from the divisions of general, gynecologic and urologic surgery 
decided that their patients would receive compression stockings for most procedures. 
Individual surgeons were free to vary from the consensus, including the option of both 
forms of prophylaxis for high risk patients, or canceling prophylaxis altogether if they 
thought it not appropriate for the case. 
Refining the Database Search 
A second database search of IHC's Enterprise Data Warehouse was then done, 
this time specific for the procedures listed by the surgeons, with the time frame limited to 
3 months (November 1996 to January 1997). The period of 3 months was selected to 
allow a sufficient number of cases to show statistical significance at the level of groups of 
similar procedures where current rates of prophylaxis fell short (see Calculation of 
Sample Size below). The same methods and SQL statements were used to search the 
EDW for the 3-month period as were used in the initial queries for the year 1996. The 
results of the second database search formed the baseline prophylaxis rate in the historic 
controls, to which the study group was compared. 
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The dates of the second database search were selected to coincide with the dates 
of data collection for the study group (November 1997 to January 1998) to rule out any 
bias due to seasonal variation. One concern was that the collection dates for the study 
group included the winter holiday season; a comparison with summer or fall months may 
not be equitable, as the number and types of surgeries done may vary by season. For 
example, few patients want elective major surgery around Christmas or New Year's Day. 
Therefore, the same months of the year were used to measure the DVT prophylaxis rates 
in both the historic controls and the study group in an attempt to have similar numbers 
and types of cases. 
Of note, not all of the procedures listed by the surgeons had cases in the database, 
as shown in Table 2. 
The reason for the discrepancy is twofold. First, the list of procedures for DVT 
prophylaxis contained a number of uncommon procedures which may not have been done 
during the period covered by the query. For example, the general surgeons listed spleno-
renal shunt as a procedure requiring DVT prophylaxis, yet only a few of these rare 
procedures are done each year at LDS Hospital. 
Table 2. Procedures selected for DVT prophylaxis and procedures found in the EDW 
database. 
Division Procedures listed for Procedures found in 
DVT prophylaxis ED W database 
General Surgery 93 33 
Orthopedic Surgery 36 12 
Gyne Surgery 60 15 
Urological Surgery 25 11 
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The second reason is that the PTXT coding system will often give several 
different codes to what is essentially the same procedure. The PTXT surgical procedure 
codes were originally developed to assist in case cart preparations. Case carts contain all 
of the instruments and materials necessary to perform the procedure. The same procedure 
may be done with different instruments, according to surgeon preference, and thus a 
procedure may have more than 1 PTXT code but only 1 corresponding ICD9 code. For 
example, there are 10 PTXT codes for total abdominal hysterectomy, yet only 1 ICD9 
code for total abdominal hysterectomy. Two PTXT codes exist for ankle fusion; again, 
there is only 1 corresponding ICD9 code. Over time, surgeons come to prefer one case 
cart set up over another, and although some PTXT procedure code still exist in the HELP 
system, they may no longer be used for any cases. 
For the rest of the thesis, the redundant codes for identical procedures and codes 
for procedures which had no cases in the database were not listed in the results. 
The full results of this second database search, which formed the DVT 
prophylaxis rates in the historic controls, are presented in Appendix F. In summary, the 
search yielded an initial baseline prophylaxis rate of 74.1 % (757 of 1021 cases). The 
database search was followed by a manual chart audit, as a concern was how accurately 
the electronic record captured patient data. Both false positives (prophylaxis 
electronically charted but not given) and false negatives (prophylaxis given but not 
electronically charted) could exist. 
False positives are errors of commission where the nursing staff charts a 
medication or device into the HELP system that patient did not receive. Approximately 
30 charts were audited for a variety of procedures where prophylaxis was electronically 
charted; no false positives were found. The false positive rate for the control group was 
considered to be effectively zero. 
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False negatives are errors of omission and can exist if the patient received a 
medication or used a device and the fact was not charted in the computer. A medication 
or device may not have been electronically charted but may be manually documented in 
the paper chart. Therefore, in order to determine if any false negatives existed, a manual 
chart review was done for all 264 patient charts which did not have DVT prophylaxis 
recorded in the EDW database. The results of the manual chart review are summarized 
in Figure 3. 
The n1anual chart review showed that for the 264 charts with no apparent DVT 
prophylaxis, 6 charts were not located or were unavailable for review. Thirty-six cases 
had the wrong facility code as they had been done at the Surgicenter, which is another 
surgical facility across the street from LDS Hospital. Most of these cases (25/36) were of 
a single procedure (panniculectomy). Surgicenter cases were not part of the study; 
therefore these 36 cases were excluded from the study. 
Twenty-two cases had been coded as myomectomies. Because of an uncertainty 
over what constituted a myomectomy versus a biopsy, this procedure was dropped from 
the study. Sixteen cases had the wrong primary procedure code. When the primary 
procedure code was corrected to reflect the procedure that had actually been done, 7 cases 
fell under procedures listed for DVT prophylaxis and so were retained in the study. For 
eXaIuple, a case which had been coded as a pelvic IYlllphadenectomy was actually a 
mastectonlY with axillery node dissection. Two cases coded as total hip replacements 
were repairs of hip fractures. 
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Figure 3. Flowchart showing change in baseline rate of prophylaxis. The initial baseline 
rate of prophylaxis of 74.1 % (757 of 1021 cases) changed to 83.80/0 (794 of 948 cases) 
after manual chart review. 
F or the remaining 9 miscoded cases, 3 cases coded as hip fractures were actually 
fractures of the clavicle. A collagen injection of the urethra was miscoded as a urethral 
suspension. Three times a cesium injection had been incorrectly coded as an iliac node 
dissection. On one occasion a patient was readmitted shortly after discharge and given the 
same primary procedure code as the previous admission, even though no procedure was 
done during the second admission. A percutaneous endoscopic gastostomy (PEG) 
procedure was miscoded as a bowel resection. All 9 miscoded cases were eliminated 
from the control group. 
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After the 73 cases were eliminated, 191 apparently negative cases remained in the 
control group. Review of these charts showed that 37 had some form of DVT 
prophylaxis recorded in the paper chart, for a false negative rate of 19%. Of the 37 cases 
which were false negatives, over half fell into just 2 procedures - laparoscopic 
appendectomy and laparoscopic cholecystectomy. These 2 procedures are often done as 
emergency cases and utilize SCDs for DVT prophylaxis. Each case should have a new 
SCD machine and leg wrappings; it is possible that late at night or on weekends some of 
the machines are reused and not charged to the second patient. No financial charge, and 
therefore no computer record of the SCDs, would exist, but the handwritten OR record 
documented the presence of the SCDs. The remaining false negatives were scattered 
throughout a number of procedures. For example, of the 11 thyroid cases thought not to 
have DVT prophylaxis, 2 cases had SCDs manually documented in the OR chart. 
In summary, of the original 1021 cases in the historic controls, 757 cases were 
considered true positives. The 264 cases with no DVT prophylaxis recorded in the EDW 
were all manually reviewed. Seventy-three cases were dropped from the study for various 
reasons, listed above. Of the remaining 191 cases, 37 were false negatives. The rate of 
DVT prophylaxis in the historic controls was therefore 794 of948 cases, or 83.8%. 
For the division of general surgery, the baseline rate of DVT prophylaxis was 
86.00/0 (416 of 484 procedures), orthopedic surgery 87.70/0 (1 71/195), gynecologic surgery 
74.10/0 (152/205), and urological surgery 85.90/0 (55/64). The breakdown by individual 
procedure is given in Appendix F. 
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The baseline rate of 83.8% DVT prophylaxis in the historic controls from 
November 1996 to January 1997 was higher than the rate of 73.3%) which was measured 
for the year 1996 at LDS Hospital. Two reasons explain the difference in rates. In the 
query for the year of 1996, several procedures with low prophylaxis rates were included 
which were not in the second query. For example, the initial query included the 
procedures of lower limb amputations (prophylaxis rate of 630/0) and TURPs (prophylaxis 
rate of 11 %). These procedures were not included in the consensus for procedures 
requiring DVT prophylaxis and were excluded from the second query. The second reason 
is that the negative cases in the 1996 query did not have a manual chart review to 
detennine the rate of false negatives, as was done for the November 1996 to January 1997 
query. 
Calculation of Sample Size 
Sample size calculations are for the chi square test of a pre- and poststudy change 
in compliance. The arcsine transformation method was used to calculate sample size 
necessary to demonstrate statistical significance for a I-tailed alpha of .05, power of 80 
(114). 
The sample size n depends on 2 factors: the known starting rate and the desired 
concluding rate. Table 3 for a final rate of 90% and Table 4 for a final rate of 80% are 
shown below. If, for eXaInple, the goal were to demonstrate statistical significance in a 
change [ron1 a rate of 30% to a rate of 900/0 (the first row of Table 3), then n = 10 was 
needed. If, however, the goal were to change from 70% to 80% (the final row of Table 
4), then n = 300 was required to demonstrate statistical significance. 
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Table 3. Sample size n required to demonstrate statistical significance when increasing a 
proportion from X to 900/0. 
x 
r rho Px rho P90 h (delta rho) n 
300/0 1.159 2.498 1.339 10 
500/0 1.571 2.498 0.927 15 
600/0 1.772 2.498 0.726 25 
70% 1.982 2.498 0.516 50 
800/0 2.214 2.498 0.284 140 
85% 2.346 2.498 0.152 >1000 
Table 4. Sample size n required to demonstrate statistical significance when increasing a 
proportion from X to 80%. 
x rho Px rho P80 h (delta rho) n 
20% 0.927 2.214 1.287 10 
30% 1.159 2.214 1.055 11 
600/0 1.571 2.214 0.643 30 
600/0 1.772 2.214 0.437 75 
700/0 1.982 2.214 0.232 300 
Analysis for statistical significance between the control and study groups was 
carried out at 4 levels - the individual procedure, groups of similar procedures within a 
division, between divisions, and all cases combined. The levels of analysis are shown in 
Figure 4. 
With the sample size varying according to the rates of pre- and poststudy 
compliance, the duration of the study depended on the level at which significance would 
be demonstrated. For some individual procedures, few cases are done and considerable 
time would be necessary to accumulate the numbers needed to establish statistical 
significance. For example, in all of 1996 there were only 23 simple mastectomies at LDS 
Hospital, of which 12 received DVT prophylaxis, for a rate of 52%. To increase the rate 
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Figure 4. Flowchart of levels of statistical analysis. For simplicity of presentation, only 1 
Division and group are broken down into their components. 
to 800/0, approximately 30 subjects would be needed to demonstrate statistical 
significance. Given the number of mastectomies performed at LDS Hospital, such a study 
would take over a year. If the goal was to increase the rate to 90%, then only 15 subjects 
would be needed and the study could be done in 6 months' time. However, if simple 
mastectomies (n = 23, rate of 52%) are combined with modified radical mastectomies (n 
= 82, rate of 65%), then the resultant category of 'breast surgery' would have n 105, 
rate of 60%. To increase this rate to 800/0, 75 cases would be needed to demonstrate 
statistical significance, which would take 9 months. However, if the rate of DVT 
prophylaxis was increased to 90%, then only 25 subjects would be needed to demonstrate 
significance, a number which could be accumulated over 3 months. 
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By combining individual procedures into groups of similar procedures (see Figure 
4) and setting a Minimal Acceptable Standard (MAS) of 900/0 compliance, it was 
determined that 3 months of cases would provide sufficient numbers to demonstrate a 
statistically significant difference in rates of compliance for most groups of similar 
procedures, such as in the example above of joining different types of breast surgeries 
into a single group. Given the limited number of cases expected to accumulate for any 1 
individual procedure, statistical significance at the level of individual procedures was not 
expected, especially for procedures with relatively low numbers of cases or where the rate 
of prophylaxis was already close to the MAS of 90%. 
The Computerized Reminder 
The next step in the study was to place a computerized reminder on the operating 
room schedule, which was generated through the HELP system (85). When a surgeon 
had a case, he or she requested OR time through the surgical booking office. At that 
point, the case existed as text only, e.g., "repair of epigastric hernia'. A PTXT procedure 
code was then assigned by the surgical staff who assenlbled the case carts; the code is 
assigned at 10:00 anl the day prior to surgery. The PTXT procedure code for epigastric 
hernia is 14.77 and once assigned forms part of the electronic data in the OR schedule, 
although it is not printed out in the paper version. The PTXT procedure code also 
beconles part of the patient's clinical electronic record. 
Case carts contain all of the instrunlents and nlaterials necessary to perform the 
procedure. For an epigastric hernia repair, a case cart will contain scalpels, retractors, 
sutures, etc. SCDs are not sent to the OR with the case cart unless requested. 
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The printed OR schedule was modified so that the letters DVT appeared next to 
the patient's name if that patient had a procedure scheduled which fell into the list of 
operations approved of by the participating divisions of surgery. An example of the 
modified OR schedule is shown in Appendix F. The second column from the left 
contains the DVT reminder. The program for the DVT reminder was written in Tandem 
Application Language (TAL) by Kyle Johnson, a programmer at LDS Hospital. The 
program ran 3 times per day via a time drive mechanism at 07 :00, 11 :00 and 15 :00. 
Figure 5 illustrates the relationships between the OR schedule, the patient's 
integrated clinical record, the knowledge base, the time driver, and the computerized 
























Figure 5. Schematic drawing of the HELP systen1. Information from numerous sources, 
including the surgery schedule, is combined into a central database. The dark circle 
represents the data drive capability of the system (115). 
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procedure code, the PTXT code becomes part of the surgery schedule and the patient's 
electronic clinical record. Three times a day the time drive mechanism searches the 
integrated clinical database on a subset of patients scheduled for surgery, checking for 
PTXT procedure codes which are contained in the knowledge base for DVT prophylaxis. 
When a match is found, there is output in the form of a DVT reminder printed on the OR 
schedule adjacent to the name of the patient, as shown in Appendix G. 
A Change in Work Pattern 
The letters DVT printed in the OR schedule served as a reminder to ensure that 
the patients with the reminder had received DVT prophylaxis. The reminder was directed 
at 3 groups of employees who work with surgical patients and the OR schedule - the 
nurses on the floor, the surgical staff, and the nurses in the OR. The author met 
separately with each of these groups to review their contribution to the study. 
For the nurses on the floor, a DVT reminder meant to check that the patient had 
received a dose of anticoagulant Goint replacement cases) or else had elastic stockings in 
place. Elastic stockings are used at LDS Hospital as an adjunct to pneumatic 
compression stockings and are placed on the patient's legs by the floor nurses before the 
patient goes to the OR. The nursing units most affected by this study were 3 North (short 
stay surgery) and 3 West (orthopedics). 
The surgical staff assemble the case carts in a central corridor adjacent to the 
operating rooms. The personnel who put together the case carts work off both the printed 
and electronic versions of the OR schedule and used the list of cases provided by the 
surgeons to determine when to include compression stockings on the cart along with 
other operative equipment. The case cart equipment lists were altered to include SCDs 
for the procedures in the study. 
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The OR nurses were responsible for placing SCDs on the patients legs after the 
induction of general anesthetic. When the patient arrived in the operating room, the DVT 
reminder on the schedule, plus the presence of elastic stockings on the legs, plus the 
presence of SCDs on the case cart served as 'triple therapy' to ensure that the patient had 
the SCDs in place prior to starting the procedure. 
For joint replacement patients, an established protocol was followed where the 
nurses on the orthopedic floor checked with the patient to ascertain that the preoperative 
dose of anticoagulant was properly administered. Patients were expected to take 10 mg 
of coumadin at home the night before their surgery. If they missed the dose, they were 
given 5 mg of coumadin the morning of surgery. Postoperatively patients were placed on 
a sliding scale of coumadin, with the dosage linked to the results of the INR lab test. An 
exception to the protocol was practiced by 1 surgeon who placed all his total knee joint 
patients on low molecular weight heparin (LMWH). 
As an aide for the nurses, posters with an explanation of the DVT reminder were 
placed on the floor and in the operating theaters. A sample of the poster is found in 
Appendix H. 
Prior to starting the study, a final meeting was held on October 20, 1997, with the 
author plus representatives from Material Management, the nursing staff, the operating 
room staff, Central Processing, Administration, and the HELP programmer who wrote the 
TAL progratTI for the DVT reminder. This nleeting was to ensure coordination between 
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the different departments whose collaboration was essential for the success of the project. 
At this meeting, the date to 'go live' with the project was set as November 3, 1997. 
November 1 and 2 were a Saturday and Sunday, and it was felt best to start on a regular 
work day with scheduled cases instead of the weekend when only emergency cases were 
performed. 
A week of' dry runs' were conducted to ensure the program for the reminder was 
working correctly_ While the nursing units and operating room received the regular, 
unmodified OR schedule, another schedule was printed with the DVT reminder in place 
and was manually reviewed by the author for accuracy_ With no evident problems, the 
study started on its scheduled date of November 3. 
Legal Considerations 
A final concern concerned the legal issues at hand. During the meetings with the 
surgeons, the question was raised of possible increased liability caused by the DVT 
reminder on the OR schedule. If the surgery schedule indicated that the patient should 
have some form of prophylaxis, and none was given, and the patient later developed a 
DVT or PE, was there an increased medical liability? 
There are 2 indicators that the DVT reminder did not pose an increased medical 
liability. The first reassurance came through the example of the preoperative antibiotic 
reminder already in place on the OR schedule. The 'abx' reminder has been present for 
over 7 years, and there has never been a lawsuit launched over its inclusion on a patient's 
record (private correspondence, Dr. Scott Evans to Dr. Robert Patterson, August 8,1997). 
The second reassurance came through a conversation with one of Intermountain 
Health Care's lawyers, Mr. James Gilson, who is familiar with the issues regarding 
reminders appearing on the OR schedule. According to Mr. Gilson, the presence of a 
reminder is merely a reflection of practice standards already in the medical community 
and should not constitute a significant increase in medical liability. 
One way to reinforce this concept was the wording found in the footnotes at the 
end of the surgery schedule. The 'abx' footnote was as follows: 
abx - A parenteral antibiotic is commonly given for this patient's surgery. If 
given, prophylactic antibiotics should be started 0 - 2 hours before surgery and 
discontinued 24 hours after surgery (emphasis by author). 
The 'DVT' footnote read as follows: 
DVT - Prophylaxis for DVT is often indicated for this procedure, and may 
consist of coumadin, heparin, pneumatic compression devices, or a combination thereof 
(emphasis by author). 
Gathering Data 
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A feature of the IHC's Enterprise Data Warehouse is that data are not entered and 
stored there until 6 to 9 months after the patient's discharge date. The search for data in 
the historic control group was not hindered by this delay, because the control group had 
surgery 1 year prior to the study group. To accumulate daily information on procedures 
and prophylaxis for the study group, it was preferable to directly query the HELP system 
inpatient database, which stores information from the time of admission until 10 days 
after discharge. Similarly, the AS400 keeps a current database on patients who received 
40 
SCDs. The HELP inpatient database and the AS400 database together provided up-to-
the-day data for the study group on procedures and prophylaxis, rather than having to wait 
6 to 9 months for the same data to appear in the ED W. 
To determine if a patient had received DVT prophylaxis, a program was designed 
for the HELP system to query the inpatient database. Written in PTXT Application 
Language (PAL), the program compiled a daily list of patients who were scheduled for 
DVT prophylaxis, and then queried the database to see if an anticoagulant had been 
given. The query was done in PAL by using a BUILD statement to construct a 
relationship for patients who had received appropriate anticoagulation, as reflected by a 
PTXT code for medication in their electronic record. Of note, when building the 
relationship, it was necessary to query for PTXT code class 48 medications, indicating 
that the medication had been given, as opposed to class 8 medication codes, which only 
indicate that a drug has been ordered. A copy of the PAL program is included as 
Appendix I. 
The report also included the date of the procedure, the patient's name, encounter 
number, OR theater, and PTXT procedure code. The report was generated on the HELP 
system, and then the data were transferred using a standard File Transfer Protocol 
program (WS_FTP32.EXE) into Microsoft Word. A typical day's report is included as 
Appendix 1. 
Patients who received SCDs for prophylaxis did not have a PTXT code for SCDs 
in the HELP system. Instead, the AS400 generated a daily list of patients who received 
SCDs. The AS400 list was then compared to the PAL report for study patients and any 
exceptions were noted. 
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In some cases both the daily PAL report for chemoprophylaxis and the daily 
AS400 report for SCDs did not list a patient who had a procedure in the study. Some 
nonjoint replacement patients may have been preadmitted to the floor, instead of coming 
through the same-day admission area. These patients often had SCDs ordered for them 
on the floor, and this infornlation would not appear in the AS400 daily report for SCDs 
ordered in the operating room. Another problem arose when an emergency case was 
added to the list. These patients might receive SCDs but this was not reflected in the 
daily AS400 report, which was prepared a day ahead of time and dealt with regularly 
scheduled cases only. 
For patients without any apparent DVT prophylaxis, the AS400 database was 
directly queried using the encounter number generated by the PAL report several days 
after the surgical procedure. If there was still no indication that SCDs were used, then a 
search of the paper chart was done to determine if any manual documentation of SCDs or 
chemoprophylxis existed. The process of determining if study patients received DVT 
prophylaxis is outlined in the flowchart in Figure 6. 
Recording Data 
Data was recorded from November 3, 1997 to January 31, 1998 and stored into 2 
Excel spreadsheets. The first spreadsheet was a day-to-day tally of the number of cases 
done and whether or not prophylaxis was provided. The second spreadsheet was a 
summary of each type of procedure in the study with number of cases performed and 
number of cases which received prophylaxis. In the second spreadsheet, cases were 
organized by individual procedure, groups of similar procedures, surgical divisions, and 
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PAL program run on 
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patients not having 
a procedure requiring 
DVT prophylaxis 
(not in study) 
chemoprophylaxis given 
(patient had prophylaxis) 
no chemoprophylaxis 




for SCD charges 
I 
I 
SCDs documented SCDs not documented 
in AS400 in AS400 
(patient had prophylaxis) 
I 
manual review 
of paper chart 
I 
SCDS or anticoagulants 
documented in paper chart 
(patient had prophylaxis) 
J 
no documentaion 
ofSCDs or anticoagulants 
(patient did not receive 
DVT prophylaxis) 
Figure 6. Flowchart of method of determining DVT prophylaxis status. 
all cases combined. 
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III. RESULTS 
Data gathering for the study group took place from November 3,1997, to January 
31,1998. During this time, 1126 operative cases met the criteria for DVT prophylaxis as 
established prior to starting the study. The daily enumeration of cases with and without 
prophylaxis is found in Appendix K. The distribution of cases by division and procedure 
is in Appendix L. 
Summary of Cases in Study 
One thousand twenty-seven cases had the DVT reminder appear on the OR 
schedule. Seventy-six of these cases were mislabeled, i.e., did not require DVT 
prophylaxis. These 76 cases were not included in the results of this study. 
One hundred sixty-two cases were 'add-ons' or emergency cases which went to 
the OR on an urgent basis. These cases qualified for DVT prophylaxis but did not have 
the DVT reminder appear on the OR schedule as the patient went straight to surgery. 
Thirteen cases which qualified for DVT prophylaxis were regularly scheduled but 
did not have the DVT reminder appear on the OR schedule; i.e., these cases were missing 
the DVT prophylaxis label. The reason is explained in the Discussion section, below. 
To calculate the number of cases which were included in the trial: 
No. of cases = reminders + add-ons + missing labels - mislabels 
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= 1027+ 162+ 13 -76 
1126 
Each of the 1126 cases may have had compression devices, anti-coagulation, both or 
neither. The breakdown by type of prophylaxis is shown in Table 5. 
Of the 1126 cases in the study, originally 25 were found not to have any form of 
DVT prophylaxis listed in the HELP system (anticoagulation) or the AS400 (SCDs). To 
verify this number, a manual chart review was done of these 25 cases. Of the 25 
suspected cases without prophylaxis, 17 had handwritten nurses notes from the operating 
and recovery rooms indicating that SCDs had been utilized. Therefore, only 8 cases out 
of 1126 did not receive DVT prophylaxis, giving a DVT prophylaxis rate of 99.30/0 for 
the study group. A breakdown of the 8 cases is shown in Table 6. 
Over the course of the study, the 1126 cases were done by 54 different surgeons. 
• Forty-seven surgeons had no cases that missed prophylaxis. 
• Six surgeons had 1 case each that n1issed prophylaxis. 
• One surgeon had 2 cases that missed prophylaxis. 
The distribution of cases without prophylaxis by surgeon showed that 1 or 2 
surgeons did not account for all of the missed cases 
Table 5. Distribution by type of DVT prophylaxis for study cases. 







Table 6. The 8 cases in the study group that did not receive DVT prophylaxis. 
Date Procedure Comments 
Nov 17 laparoscopy, open a 37-year-old female with a history of a pelvic mass 
laparotomy 
Nov 17 open laparotomy 26-year-old female, laparotomy was preceded by 
I laparoscopy 
Dec 16 ORIF tibia a traumatic fracture in an otherwise healthy 42 year 
old male 
Dec 25 ORIF hip DHS nail 82-year-old male. Lab results showed a normal 
INRiPTT. 
Jan 21 bilateral total knee This elderly patient had a previous aortic valve 
replacement replacement and was on coumadin at home. At the 
time of his orthopedic surgery, his INR was quite 
high and he was given several units of fresh frozen 
plasma. In spite of the FFP, his INR remained in 
the therapeutic range for the 5 days of his 
admission without any coumadin being given. 
Thus, although the patient did not receive any DVT 
prophylaxis during his admission, he was 
effectively anticoagulated at all times. 
Jan 22 exploratory laparotomy This teenaged male was a pedestrian struck by a car 
and was brought into emergency in extremis, with 
injuries to the head, chest, abdomen, and legs. His 
diagnostic peritoneal lavage was positive and he 
was taken straight to the OR for emergency 
laparotomy. Of note, he was hemorrhaging and 
coagulopathic and therefore not a candidate for 
anticoagulation. His leg injuries precluded 
placement of compression devices. Perioperative 
DVT prophylaxis was not indicated for this patient, 
who died on the operating room table from his 
injuries. 
Jan 29 posterior repair This 47-year-old female received elastic stockings 
but not SCDs. Elastic stockings alone are not 
considered adequate DVT prophylaxis for the 
study. 
Jan 31 sliding nail R hip This 78-year-old female was a complex renal 
patient who underwent dialysis during her 
admission. INR and PTT were always normal. 
The patient received no anticoagulation or SCDs 
during surgery or afterwards. 
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Statistical Analysis: Comparison with Historic Controls 
Originally, all cases eligible for DVT prophylaxis were to be included for 
determination of statistical significance between the study cases and the control cases. 
However, there were a few procedures done in the control group November 1996 to 
January 1997 (referred to as 1996) that were not done in the study group November 1997 
to January 1998 (referred to as 1997) and vice versa. For example, in the division of 
general surgery there were 2 cases of subcutaneous mastectomy done in 1996 and none in 
1997. Conversely, there were 2 spleno-renal shunts done in the 1997 study group, and 
none in the 1996 controls. 
If all procedures were included in the analysis, whether or not cases were done for 
that procedure in both years, the control group and study group would not have a common 
denominator. Consequently, procedures present in 1 year but not the other were 
eliminated from the study. The change to a comn10n denominator reduced the number of 
cases for analysis in 1996 from 948 to 921, and in 1997 from 1126 to 1092. 
Statistical analysis was done using 2x2 tables with significance determined by the 
chi square method. The number of cases with prophylaxis and cases without prophylaxis 
were compared from the study (Noven1ber 1997 to January 1998, called 1997 in the table) 
to the historic controls (November 1996 to January 1997, called 1996 in the table). 
An example of the method of statistical analysis is given in Table 7. In the control 
group, 9 of 26 cases of ORIF tibia had prophylaxis. In the study group, 15 of 16 cases 
had prophylaxis. The data are set up in a 2x2 table and analyzed by the chi square 
method. In this exan1ple, chi square = 14, and for 1 degree of freedom, p<.OO 1. 
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In the Division of General Surgery, 31 different types of procedures were done in 
both 1996 and 1997 (see Table 8). When analyzed for statistically significant differences 
in the rates of prophylaxis between the two, 9 of 31 procedures had a p value of .05 or 
less. In 22 procedures, there was no statistical difference between the study and the 
controls. For 18 of these 22 procedures, the preintervention rate of DVT prophylaxis was 
already greater than 900/0. Of the remaining 4 procedures, all had 6 or less cases; 
statistical significance is difficult to demonstrate with such small numbers. 
The 31 procedures were then grouped into 4 types of similar surgeries: 
1. breast - mastectomy, modified radical mastectomy, and axillery dissection 
2. neck surgery - thyroid, parathyroid, neck dissections, salivary gland surgery 
3. laparoscopic surgery - appendectomy, cholecystectomy, hernia, and Nissen 
4. open abdominal procedures - all bowel resections, laparotomies, etc. 
Results for the grouping into similar procedures are shown in Table 9. All 4 of 
the groups had a p value of < .001. Overall for the Division of General Surgery, when 
comparing DVT prophylaxis rates for similar cases between the control group and the 
study group, the study group had significantly higher rates, p < .001. 
In the Division of Orthopedic Surgery, 10 procedures were compared; only 1 of 
these showed statistical difference between 1996 and 1997, as shown in Table 10. Of the 
Table 8. General surgery cases for 1996 and 1997, showing number of cases by 
procedure, rate of DVT prophylaxis, chi square and p value. 
Procedure 96 96 percent 97 97 percent chi 
cases proph cases proph square 
abdominal I I 100% 3 3 100% 0 
perineal resection 
anterior resection 5 5 100.0% 4 4 100% 0 
axillery node I 0 0% 10 10 100% II 
dissection 
bowel resections 35 34 97% 42 42 100% 1.2 
open 17 17 100% 6 6 100% 0 
cholecystectomy 
colectomy, right 15 15 100% 7 7 100% 0 
hemi 
exploratory 6 6 100% 78 77 99% 0.1 
laparotomy 
gastric resection 4 3 75% 5 5 100% 1.4 
abdominal wall 32 17 53% 47 47 100% 27 
hernia 
mastectomy, uni,bi 7 4 57.% 10 10 100% 31 
modified radical 27 20 74% 21 21 100% 6.4 
mastectomy 
neck I 0 0% 2 2 100% 0 
dissection/sal ivary 
gland 
Nissen 4 4 100% 3 3 100% 0 
fundoplication 
,(open) 
parathyroidectomy 12 6 50% 6 6 100% 4.5 
pelvic/groin 3 2 67% '" .... 100% 1.2 .) .) 
lymphadenectomy 
sigmoid resection 15 15 100% .... 3 100% 0 .) 
splenectomy 6 5 83% 5 5 100% 0.9 
thyroidectomy 23 II 48% 19 19 100% 14 
vagotomy 1 1 100% 2 2 100% 0 
gastric bypass 14 14 100% 21 21 100% 0 
cho lecystojej unost I 1 100% 2 2 100% 0 
omy 
adrenalectomy 4 4 100% 2 2 100% ~O 
left colectomy 6 6 100% 3 .... 100% 10 .) 
pancreatic surgery 6 6 100% 13 13 100% 0 
closure colostomy 3 .... 100% 6 6 100% 0 .) 
hepatectomv 9 9 100% 8 8 100% 0 
esophago- 3 3 100% 4 4 100% 0 
gastrectomy - abd 
approach 


































Table 8, continued 
Procedure 96 96 percent 97 97 percent chi p 
cases proph cases proph square value 
laparoscopic 35 27 77% 39 39 100% 10 <.01 
appendectomy 
laparoscopic hernia 25 23 92% 47 47 100% 3.9 <.05 
repair 
laparoscopic Nissen 9 9 100% 23 23 100% 0 NS 
fundop I ication 
total 480 414 86.3% 612 611 99.8% 86 <.001 
Table 9. General surgery procedures for 1996 and 1997, grouped by similar type of 
operation. showing number of cases, rate of DVT prophylaxis, chi square and p value. 
Procedure 96 96 percent 97 97 percent chi p value 
cases proph cases proph. square 
breast surgery 35 24 69% 41 41 100% 15 <.001 
neck surgery 36 I 17 47% 27 27 100% 20 <.001 
laparoscopic 219 202 92% 277 277 100% 22 <.001 
surgery 
open abdominal 190 171 90% 267 266 99.6% 24 <.001 
procedures 
total 480 414 1 86.3% 612 611 99.8% 86 <.001 
Table 10. Orthopedic surgery procedures for 1996 and 1997, showing nurnber of cases 
per procedure, rate of DVT prophylaxis, chi square and p value. 
Procedure 96 96 percent 97 97 percent chi p 
cases proph cases proph square value 
ankle fusion 4 3 75% II II 100% 2.9 NS 
repair of hip 7 5 71% 25 23 92% 2.1 NS 
fracture 
Kuntshcner 6 5 83% 7 7 100% 0.4 NS 
nailing (lM 
rodding) 
total hip 49 49 100% 65 65 100% 0 NS 
total hip - 18 18 100% 12 12 100% 0 NS 
revision 
total knee 50 50 100% 85 84 99% 0.6 NS 
total knee - 7 7 100% 2 2 1100% 0 NS 
revision 
triple 4 3 75% I 1 100% 0.4 NS 
arthrodesis 
ORIF femur 21 96% II 11 100% 0.5 INS 
ORIF tibia 26 9 35% 16 15 94% 14 <.001 
total 193 170 188.1% 235 231 98.3% 19 <.001 
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9 procedures which did not show significance,S had preintervention rates of> 90%, and 
4 had 7 or less cases. 
The 10 procedures were then grouped into 3 types of similar surgeries: 
1. elective nonjoint replacement - ankle fusion, triple arthodesis 
2. joint replacement - total hip, total hip revision, total knee, total knee revision 
3. trauma fractures - repair of hip fracture, 1M rodding, ORIF femur, ORIF tibia 
When the orthopedic cases were combined into similar procedures, only the 
trauma fracture group showed significance, as seen in Table 11. Overall for the Division 
of Orthopedic Surgery, when comparing DVT prophylaxis rates for similar cases between 
the control group and the study group, the study group had significantly higher rates, p < 
.001. 
In the Division of Gynecologic Surgery, 10 procedures were compared between 
the study group and the control group. Five of the 10 procedures showed a statistical 
difference, as seen in Table 12. Two of the remaining 5 procedures had preintervention 
rates of> 90%, the other 3 procedures had relatively low numbers of procedures. 
The 10 procedures were then grouped into 3 types of similar surgeries: 
Table 11. Orthopedic surgery procedures for 1 996 and 1997, grouped by similar type of 
operation, showing rate of DVT prophylaxis, chi square and p value. 
Procedure 96 96 percent 97 97 percent chi p 
cases proph cases proph square value 
elective nonjoint 8 6 75% 12 12 100% 3.3 NS 
replacement 
joint replacement 124 124 100% 164 163 99% 0.7 NS 
trauma fractures 61 40 66% 59 56 95% 16 <.001 
total 193 170 88.1% 235 231 98.3% 19 <.001 
Table 12. Gynecological surgery cases for 1996 and 1997, showing number of cases by 
procedure, rate of DVT prophylaxis, chi square and p value. 
Procedure 96 96 percent 97 97 percent chi p 
cases proph cases proph square value 
laparotomy 8 4 50% 7 5 71% 0.7 NS 
Marshal Marchetti 6 3 50% 9 9 100% 5.6 <.02 
radical hysterectomy 1 1 100% 2 2 100% 0 NS 
radical vulvectomy 4 3 75% 2 2 100% 0.6 NS 
repair of cystocele 10 5 50% 10 10 100% 6.7 <.01 
and rectocele 
total abdominal 87 77 89% 88 88 100% 10.7 <.01 
hysterectomy 
vaginal 50 33 66% 55 54 98% ]9 <.001 
hysterectomy 
plain vulvectomy 5 I 20% 2 2 100% 0.5 NS 
vaginal vault 3 3 5 5 100% 0 NS 
suspension 
lap assisted vaginal 27 24 89% 30 30 100% 3.5 NS 
hysterectomy 
total 201 154 76.6% 210 207 98.6% 46 <.001 
1. open procedures - laparotomy, Marshal Marchetti, radical hysterctomy, total 
abdominal hysterectomy, vaginal vault suspension 
2. vaginal procedures - radial vulvectomy, repair of cystocele and rectocele, 
vaginal hysterectomy, plain vulvectomy 
3. laparoscopic procedures - laparoscopic assisted vaginal hysterectomy 
Two of the 3 groups showed statistical difference between the study and control 
years, seen in Table 13. Overall for the Division of Gynecological Surgery, when 
comparing DVT prophylaxis rates for similar cases between the control group and the 
study group, the study group had significantly higher rates, p < .001. 
The fourth division to participate in the study was the Division of Urology. The 
majority of surgical procedures done by the group, such as cystoscopy and transurethral 
resection of the prostate (TURP), did not require DVT prophylaxis. Therefore, the 
contribution of the Urology division to the numbers of the study was small compared to 
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Table 13. Gynecological surgery procedures for 1996 and 1997, grouped by similar type 
of operation, showing rate of DVT prophylaxis, chi square and p value. 
Procedure 96 196 percent 97 97 percent chi p value 
cases proph cases proph square 
open 105 88 84% 106 104 98% 13 <.001 
procedures 
vaginal 69 42 61% 74 73 99% 32 I <.001 
procedures 
\aparoscopic 27 24 89% 30 30 100% 3.5 INS 
procedures 
total 201 154 76.6% 210 207 98.6% 46 <.001 
the 3 other divisions. In addition, the rate of DVT prophylaxis in the control group was 
100%, leaving no room for improvement. The results for the Division of Urology are 
shown in Table 14. 
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The results for all 4 divisions are combined in Table 15. Three of the 4 divisions 
show statistical significance between the study group and the control group; the total 
difference is also highly significant (p < .001). 
In summary, 14 out of 54 individual procedures showed statistically significant 
improvement in the rate of DVT prophylaxis between the study group and the historic 
controls. The individual procedures which did not show significant improvement either 
had small numbers (8 or less cases) or had a prophylaxis rate of> 900/0 in the historic 
controls. At the next level of analysis individual procedures were combined into groups 
Table 14. Urological surgery cases for 1996 and 1997, showing number of cases by 
procedure, rate of DVT prophylaxis, chi square and p value. 
Procedure 96 96 percent 97 97 percent chi p value 
cases proph cases proph square 
nephrectomy 10 10 100% 5 5 100% 0 NS 
radical 3 3 100% i 2 12 100% 0 NS 
cystectomy 
IOO~ prostatectomy 34 34 28 100% 0 NS 
total 47 47 100% 35 35 100% 0 NS 
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Table 15. All cases for 1996 and 1997, grouped by surgical division, showing number of 
cases, rate of DVT prophylaxis, chi square and p value. 
Division 96 96 percent 97 97 percent chi p value 
cases proph cases proph square 
general 480 414 86.3% 612 611 99.8% 86 <.001 
surgery 
orthopedic 193 170 88.1% 235 231 98.3% 19' <.001 
surgery 
gynecologica 201 154 76.6% 210 207 98.6% 46 <.001 
I surgery 
urological 47 47 100% 35 35 100.0 0 NS 
surgery % 
total all 921 785 85.2% 1092 1084 99.3% 148 <.001 
divisions 
of similar procedures. Seven of 10 groups showed statistically significant improvement. 
Similarly, at the next level 3 out of 4 divisions showed statistically significant 
improvement. At the final level of analysis for all procedures in'the 4 divisions, the rate 
ofDVT prophylaxis improved from 85.20/0 in the control group to 99.3% in the study 
group (p < .001). 
IV. DISCUSSION 
The Q I Process 
The study was an attempt to increase the rate of peri operative DVT prophylaxis 
through the use of an automated computerized reminder on the operating room schedule. 
The methodology followed the basic principles of quality improvement (QI) as taught by 
Berwick and Williamson (62,102-109). The first step in the QI process was to identify a 
priority: pulmonary embolism occurring in nonprophylaxed postoperative patients. 
Postoperative complications can be minimized through appropriate use of preventative 
measures; thus the next step was to determine the rate of DVT prophylaxis. Overall, for 
the 4 participating divisions of surgery, the historic rate of prophylaxis was found to be 
83.80/0, thereby leaving room for improvement - a demonstration of Achievable Benefit 
Not Achieved (ABNA). Next a goal was set of a Minimum Acceptable Standard (MAS) 
of 900/0, and a sample size calculated. Meetings were held with the surgeons to develop 
consensus on which cases should receive prophylaxis. Plans were made for an alteration 
in work process, the crux of which was a computerized DVT reminder on the OR 
schedule. After appropriate 'buy-in' and orientation from surgical personnel, the changes 




A necessary part of this study was to implement guidelines for DVT prophylaxis, 
which were based on the recommendations of the American College of Chest Physicians 
(ACCP) (2). The value of guidelines in clinical practice is generally well accepted in the 
literature (116-124). However, published studies have shown mixed results with 
physician compliance (125-133). Despite explicit guidelines, Harpole et al. had little 
success in persuading physicians to stop ordering abdominal radiographs with a low 
clinical yield; only 40/0 of these unnecessary procedures were cancelled (127). On the 
other hand, in a meta-analysis of 59 published evaluations of clinical guidelines, 
Grimshaw and Russel concluded that all but 4 showed improvement in the process of care 
(132). 
The differences in physician compliance with guidelines were explained by Grilli 
and Lomas in their paper on the relationship between compliance rate and the subject of a 
practice guideline (134). After examining the compliance rate with 143 clinical 
recommendations in 23 different studies, the authors detected an inverse relationship 
between the complexity of a guideline and physician compliance. Plainly stated, simple 
guidelines were more likely to be followed than complicated ones. The principle of clear 
guidelines was adhered to in the present study, where DVT prophylaxis was a simple yes 
or no, and the assignn1ent was done automatically by the computer. Consequently, high 
physician compliance was achieved. Whether or not this level of compliance will 
continue is addressed later in the Discussion. 
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Comments on the Results 
The results showed a significant increase in compliance~ from 85.2% (785/921) in 
the historic controls to 99.3% (l 08411 092) in the study group, when a common 
denominator was achieved by adjustment for similar procedures. At the level of the 
individual procedure, 14 out of 54 procedures showed significant improvement; most of 
those which did not show improvement had a pre-intervention rate of> 90% or else the 
number of cases was too small (n < 8) to demonstrate significance. 
Only 8 cases out of an eligible 1126 did not receive prophylaxis, as shown in 
Table 6. Of these 8 cases, prophylaxis was contraindicated in at least 2 - the elderly male 
with a high INR from chronic coumadin use, and the young trauma patient with multiple 
injuries and coagulopathy. An argument could also be made for nonuse in the elderly 
renal patient, as these individuals often have coagulopathies which are not reflected in the 
PTT and fNR. The fact that these patients did not receive prophylaxis demonstrates the 
flexibility of the guidelines, where physicians are at liberty to decline prophylaxis if, in 
their clinical judgment, the patient does not require it. 
Five other patients who were eligible for DVT prophylaxis did not receive any 
therapy. In their paper on measuring and improving physician compliance with clinical 
practice guidelines, Ellrodt et al. (126) note that noncompliance can be caused by 
multiple factors, including physician refusal, unclear guidelines, misclassification of 
patients, change in clinical status and system inefficiencies. The study did not attempt to 
document physician rationale for not ordering prophylaxis~ and therefore the reasons why 
prophylaxis was not used for these 5 cases is unknown. Any or all of the above factors or 
other factors not discussed may have been in play. 
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The study had some patient misclassification. Seventy-six patients who were not 
in the study were mistakenly labeled with the DVT reminder, a result of the work patterns 
developed by the personnel who assemble the case carts and assign the procedure codes. 
In the HELP system, each surgical procedure has a unique PTXT code. For example, 
epigastric hernias are 14.77 and umbilical hernias are 14.74. However, the case carts for 
the 2 procedures are identical~ therefore for the convenience of the case cart assemblers 
both procedures are assigned PTXT code 14.77. 
In developing consensus on which procedures required prophylaxis, the general 
surgeons decided to cover epigastric hernias, but not umbilical hernias, as umbilical 
hernia repair almost always takes less than 30 minutes and does not fit into the ACCP 
recommendations (2). With umbilical hernias assigned the same PTXT code as epigastric 
hernia, the umbilical cases were flagged with the DVT reminder on the OR schedule. 
Similar situations arose with biopsy of cervical lymph node (assigned the PTXT code for 
neck dissection), breast biopsy (mastectomy), drainage of groin abscess (groin 
dissection), knee manipulation under anesthetic (knee replacement), and several other 
procedures. Overall, 76 out of 1027 DVT labels were inappropriate, an error rate of 
7.4%. These cases were not included in the results of the study. 
Two tactics attempted to remedy the problem of deliberate misassignment PTXT 
codes. The first was to speak with the personnel who assemble the case carts and ask 
them to alter their work process so that the correct procedure codes are assigned for each 
case. The suggestion to change established work patterns met with some resistance. The 
proposed change would require considerable effort on the part of the surgical staff as all 
new case carts must be itemized and then approved.by the surgeons. The case cart 
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assemblers did agree not to include SCDs on the case carts where prophylaxis was not 
indicated, even if there was a reminder on the OR schedule. The second strategy was to 
speak with the head nurse in the short stay area and n1ake a similar request, i.e., not to put 
elastic stockings on patients going for minor procedures, even if there was a DVT 
reminder on the OR schedule. This unit had a paper copy of all procedures included in 
the study, and so were able to screen patients appropriately. 
Another form of misclassification occurred when patients who were eligible for 
DVT prophylaxis did not receive a reminder on the OR schedule. This happened 13 
times out of964 cases (1027 labels, minus 76 inappropriate labels, plus 13 missed labels), 
an error rate of 1.3%. Two situations caused the error of omission to occur. The first 
cause was when a case was mistakenly assigned a PTXT code which did not correspond 
to the written description of the procedure. For example, a laparoscopic inguinal hernia 
repair, which was included in the study, was assigned the PTXT code for an open 
inguinal hernia repair, which was not part of the study. The second cause occurred when 
the patient had the procedure changed and the original PTXT code was not changed to 
reflect the new procedure. For example, a patient may have had a trans-thoracic 
esophagectomy scheduled (thoracic cases were not part of the study) where no reminder 
would occur, and then had the case changed to an abdominal approach, which was in the 
study. Although the text description of the case was altered, the PTXT code was not, and 
the DVT reminder did not appear on the OR schedule. 
Another area of the study that merits comment is the add-on emergency cases. 
Regularly scheduled cases were booked days or weeks in advance and were screened 
ahead of time via the time-drive mechanism in the TAL program. Eligible cases then had 
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the DVT reminder appear on the OR schedule, which was printed the morning of surgery. 
Emergency cases were added during the day on an ad hoc basis; such a case may have 
been booked at 10:00 a.m. and done at 2:00 p.m., not allowing time for the DVT 
reminder to appear on the OR schedule for that day. 
A potential solution to the problem of the static and quickly outdated paper OR 
schedule would be to introduce a 'real time' on screen OR schedule, where everyone is 
apprised of changes to the schedule as they happen. A similar system is already in use in 
the airline industry, with flight arrivals and departures updated as soon as information 
becomes available. Although not currently in place at LDS Hospital, the 'real time' OR 
schedule may be a future application of informatics technology. 
Of the 1126 cases in the study, 162 were add-ons, 14.4% of the total. These cases 
were retained in the study as the timing of bookings had not been adjusted for in the 
historic controls. Of the 8 cases that missed prophylaxis, 4 occurred in the 162 add-on 
cases and the other 4 occurred in the 964 scheduled cases. The difference was 
statistically significant with chi square = 8.6, p <.01. In other words, prophylaxis was 
more likely to be missed for an add-on case than for a scheduled case. Still, the add-on 
cases had a much higher rate of prophylaxis (158/162, 97.5%) than the historic controls 
from the previous year (794/948, 83.80/0), with chi square = 21, p <.001. 
Why was the rate of prophylaxis so high for patients who did not have the benefit 
of a DVT reminder on the OR chart? The answer was likely a combination of a 
consensus on procedures, a heightened awareness of the problem and a change in work 
process which was in effect even when the reminder was not present. Take the example 
of the Division of Orthopedic Surgery. Years prior to the present study, these surgeons 
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had reached consensus on their own that total joint replacement surgery patients should 
have DVT prophylaxis. The rate for total joint replacement surgery in the historic 
controls was 100% (1241124); the rate during the study period was 99.4% (1631164); the 
difference was not significant. 
However, prior to the study there was no consensus on prophylaxis for tibial 
fractures, and the rate of prophylaxis for ORIF tibia was only 34.60/0 (9/26) in the historic 
controls. The rate improved to 93.8% (15116) during the study, a significant difference 
with chi square = 14, P <.00 1. Yet most of these cases were add-ons; a fractured tibia 
was done right away as an emergency case and no DVT reminder appeared on the OR 
schedule. During the study period, all orthopedic surgeons agreed to treat all tibia 
fractures with prophylaxis. Furthermore, the case cart assemblers also knew that all tibia 
fractures received compression devices, whereas before it was only at the prerogative of 
the individual surgeon. 
Although it is speculative to assume a causal relationship, the combination of 
consensus, increased awareness and a change in work pattern may have led to the 
increased compliance, even in the absence of the DVT reminder. Rather than attribute 
the success of this study solely to the computerized reminder, it is likely more accurate to 
state that the reminder was part of a process which improved the delivery of care. 
Cost Issues 
The issue of cost was not addressed specifically in this study. Several studies 
have demonstrated the cost effectiveness of DVT prophylaxis (58,59), but any attempt at 
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cost effectiveness must take multiple factors into account, including the expense of 
materials in the hospital of interest. 
At LDS Hospital, the different forms of prophylaxis have the following costs 
displayed in Table 16. Cost of DVT prophylaxis will obviously vary according to the 
type and duration of therapy chosen. Table 17 calculates cost of prophylaxis for a single 
day of therapy, and a week of therapy. 
Obviously, the cost of prophylaxis will vary greatly according to choice and 
duration of therapy. In addition to the costs of the medications or devices, additional 
expenses must also be considered, such as monitoring of lab tests and complications of 
prophylaxis. Such an analysis is beyond the scope of the present study. 
Limitations of This Study 
The study has several limits, including verification of data quality, measurement 
of process outcomes in lieu of clinical outcomes and no measurement of any attrition. 
Table 16. The cost of various forms of DVT prophylaxis at LDS Hospital, February 
1998. 
Type of Prophylaxis Cost 
Sequential $11.25 per day for the machine, plus a one time charge of 
Compression Devices $58.00 for the stockings 
Plexipulse $24.90 per day for the machine, plus a one time charge of 
Compression Boots $50.00 for the boots 
coumadin (oral) $0.06 per dose, plus an administration charge of $2.33 per 
dose, for a total of $2.39 per dose 
unfractionated heparin $0.03 per dose, plus an administration charge of $12.20 per 
(injection) dose, for a total of $12.23 
low molecular weight $12.21 per dose, plus an administration charge of$12.20 per 
heparin (injection) dose, for a total of $24.41 
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Table 17. The cost of various forms ofDVT prophylaxis for a single day and for a week, 
LDS Hospital, February 1998. 
Type of Prophylaxis Cost for a single day Cost for a week 
Sequential Compression $69.25 $137.25 
Devices 
Plexipulse Compression $74.90 $224.30 
Boots 
coumadin (oral) $2.39 $16.73 (plus monitoring) 
unfractionated heparin $12.23 (single dose) $171.22 (bj.d.) 
(injection) 
low molecular weight $24.41 (single dose) $341. 74 (b.i.d.) 
heparin (injection) 
The cases during the period of the study were tallied on a day-to-day basis 
utilizing the operating room schedule and inpatient paper and electronic charts. By 
contrast, the rates for the historic controls were derived from an administrative database. 
Administrative databases have been criticized as an inaccurate reflection of the clinical 
record (135,136). The data in the EDW database can1e from a variety of sources. The 
ICD9 procedure codes in the EDW were originally PTXT procedure codes in the HELP 
system. Medications listed in the ED W were PTXT codes in HELP before, then charge 
codes in the AS400 financial system. The charge codes for SCDs came directly from the 
AS400 without ever being part of the HELP system. The question begs - how accurate is 
this information? 
Key causes of difficulties with information quality were outlined by Strong et al. 
(137). In brief, data may be inaccurately produced, incorrectly stored in a database, or 
retrieved in an erroneous fashion. 
It is possible that a patient received a therapy that was not captured in the 
computer system (inaccurate production of information), more probable for SCDs than 
64 
anticoagulants. Nurses have a strict process for recording medications in the electronic 
chart, so lack of a medication code is unlikely to be a source of error. During the 3 month 
study period, no instances were discovered of an anticoagulated patient who did not have 
the medication recorded in the electronic chart (234 cases). More likely, a patient might 
receive SCDs without this being recorded in the AS400 computer, and therefore this 
information would not appear in the daily listings of SCD devices or as a charge code in 
the EDW. 
Electronically unrecorded SCDs occurred 17 times out of 932 cases during the 
study, an incidence of 1.8%. The majority of the cases (11117) were add-ons and 
occurred late at night or on weekends. SCD machines should be serviced between 
patients and the charge code information is captured with the servicing. With late night 
cases the same machine was likely used for 2 patients without being serviced in between. 
Although reuse of SCD machines is not standard nursing practice, it may have been 
necessitated by an additional machine not being available at that time of day. Prophylaxis 
with a nonserviced machine is better than no prophylaxis at all. The problem of 
electronically unrecorded SCDs was an unrecognized process error identified by the 
study. 
The small number of unrecorded SCD machines likely had minimal impact on the 
results. Even if an additional 2% of the historic control patients had received SCDs, the 
difference between the study and control groups would still be highly significant. 
One unanticipated challenge with information quality occurred in the historic 
controls, when the cases with DVT prophylaxis were manually audited for accuracy. Of 
the 264 cases, 73 were removed from the study, a high number (see Figure 3). Forty-five 
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cases were removed because of incorrect codes. Nine cases had an incorrect procedure 
code while 36 cases had an incorrect facility code. The study did not attempt to 
document where errors in coding occurred. The discrepancies between the paper and 
electronic records outline the problems that can arise when multiple records exists and 
information is converted from one form to another. Maintenance of data integrity is an 
important issue, but not the focus of the study and is not commented on further except to 
repeat that data accuracy was ensured by the manual audit of records. 
Another limitation to the study was process outcomes were measured in lieu of 
clinical outcomes. Ultimately, clinical outcomes are the object of interest. For example, 
in their work with a reminder for preoperative antibiotics, Classen et al. initially showed a 
change in process outcome (an increased rate of pre-operative antibiotic administration 
from 40% to 990/0), and in a follow up study were also able to demonstrate a decrease in 
the incidence of postoperative wound infections, from 20/0 to 0.4% (93). 
Ideally, the present study would have shown a decrease in the rate of pulmonary 
embolism (PE). Two difficulties exist with demonstrating a decrease in the incidence of 
postoperative PEs. The first is that PEs are a relatively rare event, occurring only once 
per month on average in surgical patients without prophylaxis at LDS Hospital according 
to the leOPER data (see Appendix 3). Prophylaxis can prevent up to 800/0 of PEs but 
does not eliminate them all. To demonstrate a change from an average of 10-12 PEs per 
year to an average of 3-4 PEs per year would require gathering data for several years 
instead of the 3 months allotted to the study. 
The second difficulty is that not all patients return to LDS Hospital for their 
postoperative care. A PE can occur anywhere from 1 week to several months after a 
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surgical procedure (21). By that time the patient may have returned home to a different 
city or state, and could be treated for complications at another facility without that data 
ever making its way into the patient's record at LOS Hospital. Also, the presentation of a 
PE may be sudden death, yet families of elderly patients will frequently decline autopsies 
and the cause of death remains unknown. Given the current patterns of practice the true 
incidence of PE in patients who have had their surgery at LOS Hospital remains 
unknown. 
Is it acceptable to perform a study that measures process outcomes instead of 
clinical outcomes? In their paper on designing studies of computer-based alerts and 
reminders, Rind et al. address this question and conclude that the clinical value of 
measuring process outcomes can be determined if adequate data exist for the procedure or 
behavior that the reminder addresses (69). Investigators have thoroughly documented the 
effectiveness of prophylaxis against postoperative OVT and PE (2,3). The purpose of the 
study was not to demonstrate a relationship between prophylaxis and thromboembolism, 
but rather to increase appropriate use of prophylaxis. Although the study would be 
strengthened if it had shown a decrease in thromboembolic disease, it may be safely 
inferred that an increase in the rate of prophylaxis will lead to a decrease in the incidence 
of OVT and PE. 
Finally, the study showed an increase in the rate of prophylaxis during the 3 
months of the trial, but it is unknown if this effect will be sustained after the study is 
concluded. The effect of a computer generated alert is subject to attrition, as was seen in 
the Veterans Affair Collaborative Controlled Clinical Trial #9 (138). Ideally, OVT 
prophylaxis rates at LOS Hospital should be measured again in a year to see if 
67 
compliance remains high. With the combination of a consensus among the surgeons, a 
change in work patterns among surgical personnel, heightened awareness of the need for 
DVT prophylaxis and a consistent computerized reminder, the rate of prophylaxis will 
hopefully remain close to its current level of 99.30/0. 
V. SUMMARY AND CONCLUSION 
The study was entitled "A Computerized Reminder for Prophylaxis of Deep Vein 
Thrombosis in Surgical Patients." The study examined the historic rate of DVT 
prophylaxis for surgical patients at LDS Hospital and found room for improvement. 
Consensus was developed with the hospital's surgeons over which procedures should 
have prophylaxis. An automated reminder was then placed on the hospital's computer 
system to flag those patients for whom DVT prophylaxis was indicated. Surgical 
personnel including surgeons, nurses and case cart assemblers were alerted to a change in 
their work pattern. After gathering data for 3 months on 1126 patients, the rate of DVT 
prophylaxis in surgical patients improved from 83.80/0 in the historic controls to 99.30/0 in 
the study group. The difference in rates was highly statistically significant (p<.OO 1 ). 
The success of the study was recognized by members of the participating divisions 
of surgery, and the DVT reminder was left in place after the conclusion of the study. The 
reminder will be maintained at LDS Hospital by the programmer and pulmonary 
physician who aided in the study. 
The study has shown that a computerized reminder, combined with other 
measures such education, forming consensus and changing work patterns, appeared to be 
an effective method of increasing the rate of DVT prophylaxis in surgical patients. 
APPENDIX A 
TEXT OF LETTER OF INVITATION TO PARTICIPATE IN 




Dr. Robert Patterson is a general surgeon and informatics student at the University of 
Utah who is working on a project concerning DVT prophylaxis in surgical patients here at 
LDS Hospital. His plan is to place a computerized reminder on the OR schedule, similar 
to what is currently done with preoperative antibiotics. 
He and I have already met with the Departments of General, Orthopedic, and OB/GYN 
surgery and have their interest and support in the project. At a recent meeting of the 
Surgical Executive Committee, it was suggested that he extend his project to cover all 
surgical patients at LDSH, not just those in the aforementioned departments. 
Dr. Patterson would like to make a brief presentation in your departmental meeting, 
which can include data specific to the procedures perforn1ed by your surgeons. He would 
then like to work with an individual in your department to develop a list of all procedures 
for which DVT prophylaxis is considered appropriate. This will also afford you an 
opportunity to criticize and make suggestions for his work. 
I believe this study will be of value to both patients and physicians here at LDS Hospital. 
Your cooperation in this matter will certainly enhance the project and be much 
appreciated. Please let me know when such a presentation might be made to your 
department. 
Sincerely, 
Greg Elliott MD 
APPENDIX B 
DVT PROPHYLAXIS RATES FOR SELECTED 
PROCEDURES, LDS HOSPITAL, 1996 
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Table 18. General Surgery procedures, with corresponding ICD9 codes, number of cases, 
number of cases with prophylaxis, and rate of prophylaxis expressed in percent. 
Procedure ICD9 Cases Prophylaxis 0/0 
lap cholecystectomy 5123 562 494 88 
open cholecystectomy 5122 69 67 97 
abdominal wall hernia 5351 5359 133 63 47 
5361 5369 
partial or total gastrectomy 4381 a 
4389 1 100 
435 2 2 100 
436 4 4 100 
437 11 11 100 
esophagogastrectomy 4399 4 4 100 
esophagectomy 4240 4241 5 5 100 
4242 
small bowel resections 4561 4562 61 60 98 
4563 




colectomy, total intra-abd 458 14 14 100 
anterior resection 4863 8 8 100 
APR 485 4 4 100 
closure of ostomy 4651 small 5 4 80 
4652 colon 16 15 94 
exploratory laparotomy 5411 20 13 65 
Whipple 527 20 20 100 
pancreatic surgery 5251 5252 10 10 100 
5253 5259 
hepatectomy 5022 partial 25 25 100 
503 lobe 19 18 95 
thyroid 062 26 14 54 
064 27 13 48 
parathyroid 0681 2 1 50 
0689 31 18" 58 
adrenalectomy 0722 6 6 100 
0729 a 
simple mastectomy 8541 unilat 20 10 50 
8542 bilat 3 2 67 
Table 18 continued 
Procedure ICD9 Cases 
modified radical mastectomy 8543 unilat 78 
8544 bilat 4 
radical mastectomy 8545 8546 0 
Total for General SurgerY 1337 
Explanation of Column Headings: 
Procedure - the surgical procedure 
ICD9 - the ICD9 code(s) for the surgical procedure 





Prophylaxis - the number of cases which received DVT prophylaxis 






Table 19. Orthopedic Surgery procedures, with corresponding ICD9 codes, number of 
cases, number of cases with prophylaxis, and rate of prophylaxis expressed in percent. 
Procedure ICD9 Cases 
Total hips 8151 193 
Revision hips 8153 78 
Total knees 8154 206 
Revision knees 8155 23 
ORIF tib/fib 7936 124 
ORIF femur 7935 119 
Lower extremity amputations 8412 13 




ORIF humerus 7931 25 
ORIF radius/ulna 7932 53 
Shoulder repair 8180 8181 142 
8182 8183 
Total for OrthoQedic surgerY 1006 
Explanation of Column Headings: 
Procedure - the surgical procedure 
ICD9 - the ICD9 code(s) for the surgical procedure 

















Prophylaxis - the number of cases which received DVT prophylaxis 



















Table 20. Gynecological Surgery procedures, with corresponding ICD9 codes, number of 
cases, number of cases with prophylaxis, and rate of prophylaxis expressed in percent. 
Procedure ICD9 Cases Prophylaxis % 
total abdo hysterectomy 684 305 265 87 
vaginal hysterectomy 685 304 205 67 
oophrectomy and salpingo- 6551 6552 46 31 67 
oophrectomy 6561 6562 
cystocele and rectocele 705 39 22 56 
Total for Gynecologic Surgery 694 523 75.4 
Table 21. Urological Surgery procedures, with corresponding ICD9 codes, number of 
cases, number of cases with prophylaxis, and rate of prophylaxis expressed in percent. 
Procedure ICD9 Cases 
complete nephrectomy 5551 5552 68 
5553 5554 
partial nephrectomy 552 4 
sphincterotomy of bladder 5791 17 
retropubic urethral suspension 595 27 
TURP 6021 6029 124 
prostatectomy suprapubic 603 1 
retropubic 604 2 
radical 605 95 
Total for Urological SurgerY 338 
Explanation of Column Headings: 
Procedure - the surgical procedure 
ICD9 - the ICD9 code(s) for the surgical procedure 











Prophylaxis - the number of cases which received DVT prophylaxis 












Table 22. Totals for all 4 Divisions 
Division Cases Prophylaxis 0/0 
General Surgery 1337 1103 82.5 
Orthopedic Surgery 1006 653 64.9 
Gynecologic Surgery 694 523 75.4 
Urological Surgery 338 195 57.5 
Grand Total 3375 2474 73.3 
APPENDIX e 
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Table 23. Data from the lCOPER study, LDS Hospital 
Pt Proph Division Procedure 
029 Yes Ortho repair of fractured femur 
103 Yes Ortho total knee 
021 Yes Ortho total hip 
079 Yes Ortho lumbar spine decompression 
050 No Ortho cervical discectomy 
052 No Ortho repair of hi p fracture 
067 No Ortho knee arthroscopy 
074 No Ortho ORIF tibial plateau 
085 No Ortho removal of bone spur from foot 
064 Yes Gyne debulking of ovarian tumor 
078 No Gyne D&C 
083 No Gyne total abdominal hysterectomy 
044 No Gyne pelvic lymphadenectomy 
013 No Gyne total abdominal hysterectomy 
102 No Gyne total abdominal hysterectomy 
047 Yes GenSurg incisional hernia repair 
098 No GenSurg Nissen fundoplication 
033 No GenSurg biliary reconstruction/liver transplant 
016 No GenSurg thyroidectomy 
005 No GenSurg colectomy 
065 No GenSurg abdominoplasty 
087 No GenSurg laparoscopic appendectomy 
046 No Neuro craniotomy 
028 Yes Thoracic coronary artery bypass 
097 Yes Thoracic coronary artery bypass 
020 No Other debridement of shoulder post acromioplasty 
048 No Other cyst on hand 
Pt: patient number as enrolled in lCOPER study 
Proph indicates whether or not the patient had prophylaxis at the time of surgery 
Department indicates which surgical division did the procedure 
Procedure the specific surgical procedure which preceded the pulmonary embolism 
APPENDIXD 
SUMMARY OF ACCP RECOMMENDATIONS 
FOR DVT PROPHYLAXIS 
1. Low Risk Patients 
<40 years old 
minor surgery 
no other risk factors 
DVT Prophylaxis: none recommended 
2. Moderate Risk Patients 
>40 years old 
major surgery 
no other risk factors 
DVT Prophylaxis: ES or LDUH or IPC 
3. High Risk Patients 
>40 years old 
maj or surgery 
additional risk factors 
DVT Prophylaxis: LDUH or LMWH or IPC 
4. Very High Risk Patients 




DVT Prophylaxis: LDUH or LMWH, plus IPC 
ES: graded compression elastic stockings, applied pre-op, worn until patient is 
ambulatory . 
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IPC: intermittent pneumatic compression, applied with induction of general anesthetic, 
continued post-op until patient is ambulatory. 
LDUH: low dose unfractionated heparin, given as 5,000 units s.q. q 12h or q8h. First 
dose is given 1-2 hours pre-op. Continued post-op until patient is ambulatory. 
LMWH: low molecular weight heparin, for example, enoxaparin 30 mg s.q. q12h or 40 
mg s.q. once a day. 
APPENDIX E 
PTXT PROCEDURE CODES FOR DVT PROPHYLAXIS 











































Text (from PTXT codes) 
abdominal perineal resection 
ampullary spincteroplasty 
anterior resection 
antrectomy - feeding gasrtotomy 





excision of adrenal mass 
exploratory laparotomy 




hiatal hernia repair 
incisional hernia repair 
mastectomy 
modified radical mastectomy 







radical groin dissection 
radical mastectomy 










ventral hernia repair 
gastric bypass 
cholecystoj ej unostomy 
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radical total gastrectomy - thoraco-abd approach 
colectomy, perineal pull through 
breast biopsy, possible mastectomy 
excision sub-Q maxillary gland 
chole & grams 






colostomy - Wangenstein transverse colon 
cholecystectomy with NFP 
partial colectomy with proctopexy 
trans rectal tumor with appendectomy 
wide breast biopsy, axillery node dissection 
Whipple with IORT 
gastric bypass with chole 
resect perineal tumor 




esophago-gastrectomy - abd approach 
loop colostomy with bridge 
vagotomy/antrectomy 
spleno-renal shunt 
total colectomy, ileostomy, endo-rectal pull through 
right hepatic lobe resection 
left hepatic lobe resection 
pancreatic abscess (debridement) 
abdominal debridement 
laparoscopic cholecystectomy, possible open 
laparoscopy (general surgery) 
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Text (from PTXT codes) 
laparoscopic appendectomy 
laparoscopic inguinal hernia repair 
laparoscopic bowel resection 
laparoscopic Nissen fundoplication 
laparoscopy/liver biopsy 
laparoscopic colostomy take-down 
laparoscopic right colectomy 
laparoscopic colectomy 
thoraco-abdominal esophageal resection 
excision of esophageal diverticulum 
spenal renal shunt 
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Text (from PTXT codes) 
laparotomy, BSO, incidental appendectomy 
laparotomy, cysto, and procto 
laparotomy, ectopic pregnancy 
laparotomy, ovarian cystectomy 
laparotomy, tubal plasty 
lap, uterine susp, pre sacral neurectomy 
laparoscopy, hysterectomy 
laparoscopy, laparotomy, D & C 
laparoscopy, laparotomy for infertility 
laparoscopy, laparotomy for pelvic pain 
laparoscopy, laparotomy, tubal plasty 




repair of cystocele 
repair of cystocele and rectocele 
repair of rectocele 
total abdominal hysterectomy 
TAH,MMK 
TAH, Marshal Marchetti, repair of cystocele and rectocele 
total abdominal hysterectomy, repair of rectocele 
vaginal hysterectomy 
vaginal hysterectomy, cysto, procto, and rectocele 
vaginal hysterectomy and rectocele repair 
vag hyst A&P repair 
vaginal vault suspension, abdominally 
vaginal vault suspension, vaginally 
wedge resection of ovary 
exploratory laparotomy, lysis of adhesions 
exploratory laparotomy, uterine suspension 
expllap, wedge resection of ovary 
colpoleisis 
vaginal hysterectomy, anterior repair 
plain vulvectomy 
total abdominal hysterectomy, BSO 
total abdominal hysterectomy with nodes 
vaginal hysterecton1Y with cone biopsy 
pre-sacral neurectomy 
exploratory laparotomy, insertion of template 
bladder suspension 
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Text (from PTXT codes) 
D&C, TAH 
laparotomy, tubal plasty, microsurgery 
tubal reanastamosis 
myomectomy 
La Forte procedure 
T AH/Birch urethropexy 
TAH, Birch, rectocele and cystocele repair 
vaginal rectal fistula repair 
vaginal vault suspension, abdominally and vaginally 
para-vaginal retropubic repair 
lateral vaginal wall suspension 
laparoscopic assisted vaginal hysterectomy 
TAH, abdominal vag sacropexy, lat vag vault suspension 
sacral spinous vaginal vault suspension 
radical hysterectomy with lymphadenectomy 
radical hysterectomy with select nodes, cysto, procto, EUA 
neo-vagina with split thickness skin graft 
radical hysterectomy with bowel resection 
vaginectomy 
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Text (from PTXT codes) 
ankle fusion 
Haggi hip pinning 
high tibia osteotomy 
hip pinning 
sliding nail / D HS hip pinning 
Knowles hip pinning 
Kuntshcner nailing (1M rodding) 
ORIF hip joint 
o RIF large extremity 
proximal tibia osteotomy 
Thompson! Austin-Moore hip 
total ankle 
total hip 
total hip - cementless 
total hip - revision 
total knee 
triple arthrodesis 
key free hip pinning with cement 
ORIF femur 
ORIF tibia 
arthroscopy - high tibia osteotomy 
reconstruction of knee 
ORIF - tibia plateau 
key free hip pinning with cement 
1M nailing tibia 
total knee - revision 
ORIF femoral condyle 
ankle fusion with bone graft 
distal tibia osteotomy 
Richards tibial nailing 
Richards femoral nailing 
total hip - with cement 
Thompson Austin Moore endoprosthesis 
triple hip osteotomy 
bilateral total knee 
ankle fusion 
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iliac node dissection 
iliac node dissection, Il25 seeds 
nephrectomy 
nephrostomy 






radical cystectomy with ilio conduit 








graft patch urethroplasty 
lymphadenectomy, rad ret-pub pros 
penectomy 
.. U!IXJ A_L_ t 
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APPENDIXF 
RATES OF DVT PROPHYLAXIS IN THE 
HISTORIC CONTROL GROUP 
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Table 28. General Surgery procedures at LOS Hospital, November 1996 to January1997. 
For each procedure the table lists the corresponding PTXT code, the IC09 code, number 
of cases done, number of cases with prophylaxis, and rate of prophylaxis expressed in 
percent. 
General Surgery Procedure PTXT ICD9 96 cases 96 proph percent ! 
abdominal perineal resection 14.1 48.5 1 1 100.0% 
anterior resection 14.5 48.63 5 5 100.0% 
axillery node dissection 14.10 40.23 1 0 0.0% 
bowel resections 14.11 46 35 34 97.1% 
open cholecystectomy 14.14 51.22 17 17 100.0% 
colectomy, right hemi 14.15 45.73 15 15 100.0% 
exploratory laparotomy 14.24 54.11 6 6 100.0% 
gastric resection 14.6 43.6 4 .., 75.0% :> 
hiatal hernia repair 14.34 53.7 2 2 100.0% 
abdominal wall hernia 14.35.77 53.5161 32 17 53.1% 
mastectomy, uni,bi 14.44 85.4142 7 4 57.1% 
modified radical mastectomy 14.46 85.43 27 20 74.1% 
neck dissection for removal of 14.48 26.32 I 0 0.0% 
salivary gland 
Nissen fundoplication 14.49 44.66 4 4 100.0% 
parathyro idectomy 14.51 6.89 12 6 50.0% 
pelvic lymphadenectomy 14.53 40.3 3 2 66.7% 
sigmoid resection 14.64 45.76 15 15 100.0% 
splenectomy 14.65 41.5 6 5 83.3% 
subcutaneous mastectomy 14.68 85.35 2 0 0.0% 
ectomy 14.73 6.451 23 II 47.8% 
vagotomy 14.75 44.02 I I 100.0% 
gastric bypass 14.78 44.31 14 14 100.0% 
cholecystojejunostomy 14.83 51.32 I I 100.0% 
adrenalectomy 14.84 7.2122 4 4 100.0% 
pancreatic surgery 14.95 52.7 6 6 100.0% 
left colectomy 14.121 45.75 6 6 100.0% 
closure colostomy 14.155 46.52 3 3 100.0% 
hepatectomy 14.159 50.223 9 9 100.0% 
esophago-gastrectomy - abd 14.162 43.5 3 3 100.0% 
approach 
laparoscopic cholecystectomy, 14.180 51.23 150 143 95.3% 
possible open 
Japaroscopic appendectomy 14.182 47.01 35 27 77.1% 
laparoscopic hernia repair 14.183 25 23 92.0% 
laparoscopic Nissen fundopl ication 14.186 9 9 100.0% 
lOlal 484 416 86.0% 
Table 29. Orthopedic Surgery procedures at LDS Hospital, Novernber 1996 to January 
1997. For each procedure the table lists the corresponding PTXT code, the ICD9 code, 
number of cases done, number of cases with prophylaxis, and rate of prophylaxis 
expressed in percent. 
Orthopedic Surgery Procedures PTXT ICD9 96 cases 96proph percent 
ankle fusion 18.6/23.106 81.11 4 3 75.0% 
repair of hip fracture 18.47 79.39 7 5 71.40/0 
Kuntshcner nailing (1M rodding) 18.48 79.15 6 5 83.3% 
proximal tibia osteotomy 18.68 77.37 1 1 100.0% 
total hip 18.75 81.51 49 49 100.0% 
total hip - revision 18.77 81.53 18 18 100.0% 
total knee 18.78 81.54 50 50 100.0% 
triple arthrodesis 18.81 81.12 4 3 75.0% 
ORIF femur 18.102 79.35 22 21 95.5% 
ORIF tibia 18.108 79.36 26 9 34.6% 
total knee - revision 18.211 81.55 7 7 100.0% 
triple hip osteotomy 23.83 77.29 1 0 0.0% 
total 195 171 87.7% 
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Table 30. Gynecologic Surgery procedures at LDS Hospital, November 1996 to January 
1997. For each procedure the table lists the corresponding PTXT code, the ICD9 code, 
number of cases done, number of cases with prophylaxis, and rate of prophylaxis 
expressed in percent. 
Gyne Surgery Procedures PTXT ICD9 96 cases 96 proph percent 
laparotomy, 8S0, incidental appendectomy 15.9 66.51 2 0 0.0% 
laparotomy, ovarian cystectomy 15.12 66.29 6 4 66.7% 
Marshal Marchetti 15.3 59.5 6 3 50.0% 
radical hysterectomy 15.33 68.6 I I 100.0% 
radical vulvectomy 15.34 71.5 4 3 75.0% 
repair of cystocele and rectocele 15.35 70.51 3 0 0.0% 
repair of cystocele and rectocele 15.36 70.5 4 3 75.0% 
repair of rectocele 15.37 70.52 4 2 50.0% 
total abdominal hysterectomy 15.39 68.4 87 77 88.5% 
vaginal hysterectomy 15.43 68.59 50 33 66.0% 
va~inal vault suspension, abdominally 15.47 70.77 3 3 100.0% 
wedge resection of ovary 15.49 65.22 2 0 0.0% 
plain vulvectomy 15.64 71.6 5 I 20.0% 
bladder suspension 15.72 57.89 1 1 100.0% 
laparoscopic assisted vaginal hysterectomy 15.10 I 68.51 27 21 77.8% 
total 205 152 74.1% 
Table 31. Urological Surgery procedures at LDS Hospital, November 1996 to January 
1 997. For each procedure the table lists the corresponding PTXT code, the ICD9 code, 
number of cases done, number of cases with prophylaxis, and rate of prophylaxis 
expressed in percent. 
Urological Surgery Procedures PTXT ICD9 96 cases 96proph percent 
iliac node dissection, 1125 seeds 22.29 92.27 7 1 14.3% 
nephrectomy 22.32 55.5 10 10 100.0% 
open urethral suspension 22.34 59.7 5 3 60.0% 
pyelolithotomy 22.41 55.11 1 0 0.0% 
pyeloplasty 22.42 55.87 1 1 100.0% 
radical cystectomy with ilia conduit 22.45 57.71 3 3 100.0% 
retro-pubic prostatectomy 22.48 60.4 I 1 100.0% 
uretero/ileo anastamoses 22.65 56.51 1 1 100.0% 
ureterolithotomy 22.66 56.2 1 1 100.0% 
vesico/vaginal fistula 22.83 57.84 1 1 100.0% 
radical prostectomy, all types 22.91 60.5 33 33 100.0% 
total 64 55 85.9% 
92 
Table 32. Summary of all 4 Divisions at LDS Hospital, November 1996 to January 1997. 
For each Division the table lists the number of cases done, number of cases with 
prophylaxis, and rate of prophylaxis expressed in percent. 
Division 96 cases 96 pro ph percent 
General Surgery 484 416 86.0% 
Orthopedic Surgery 195 171 87.7% 
Gynecologic Surgery 205 152 74.1% 
Urological Surgery 64 55 85.9% 
total 948 794 83.8% 
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POSTER FOR DVT PROPHYLAXIS STUDY 
DVT 
Prophylaxis Study 
A new reminder now appears on 
the O.R. schedule for patients who 
receive DVT prophylaxis. 
When the DVT notice appears., 
please make sure the patient: 
a. received coumadin or heparin 
(total joint surgery patients)., or 
96 
b. has TED stockings/SeD or 
Plexipulse boots before anesthesia. 
If there are any questions, please call Dr. Robert Patterson at 321-5552. 
APPENDIX I 
CODE FOR PAL PROGRAM TO LIST PROCEDURES 
AND CHEMOPROPHYLAXIS 
98 

















































?SOURCE "$SYSTEM HELP 
?LIST 
LITERALS" 
PAL Program written by Robert Patterson MD 
with help from Kyle Johnson. Compiled November 1997. 
The purpose of this program is to determine which surgical 
patients had DVT prophylaxis. This program searches 
! a file of surgical patients who should have received DVT prophylaxis 
which can consist of coumadin, heparin, enoxaparin, or mechanical 
! devices such as Sequential Con1pression Devices (SCD) or 
! Plexipulse boots. The list of patients is then checked for PTXT codes 
that indicate prophylaxis has been given. 
This is how to compile the program 
$SYSTEM.HELP.PAL/IN $DATA2.RPATTE.DVTPRO, OUT $S.#ROBERT, 
PRI 1 OO/$DA TA2.RP A TTE.DVTPRO 
This is how to run the program 
RUN $SYSTEM.HELP.DRIVERIIN $DATA.RP A TTE.DVTPROo, 
PRI 100IFLD;N 
! beginning of the main section 
SECTION MAINE MAIN; 
BEGIN 
! naming of the variables 
VARIABLE ONE; 
V ARIABLE DATE; 
VARIABLE P"NUM CHAR [4]; 




VARIABLE PNAME CHAR [30]; 
VARIABLE PA TIENT"NUM; 
VARIABLE PROC"TEXT CHAR [60]; 
VARIABLE PROC"CODE CHAR [16]; 
VARIABLE OR"ROOM CHAR [1]; 
99 
44 ! building a relationship for chemoprophylaxis 
45 RELATION CHEMOPROPHYLAXIS 
46 BEGIN 
47 ITEM COUMADIN CODE (48 1 8 2 1 1 00); 
48 ITEM COUMA T AB CODE (48 1 58 2 3 1 0 0); 
49 ITEM HEPARIN"INJ CODE (48 1 8 2 3 2 0 0); 
50 ITEM HEPARIN"SQ CODE (48 1 8 2 3 10 0 0); 
51 ITEM ENOXAPARIN CODE (48 1 823 15200); 
52 ITEM ENOXAPTUBE CODE (48 1 81 2 21 48 0 0); 
53 ITEM HEPARIN"VIAL CODE (48 1 58 2 4 1 0 0); 
54 END; 
56 
57 ! nobody knows what this means, but everyone has it in their code 
58 PAUSE OFF; 
59 SETTIMER (0); 
60 
61 
62 OPEN "ORF SURGERY SCHEDULE LOG" AS $FILES(18) READ"ONLY; 
63 ! opening the files that contain the list of surgical patients 
64 ! this is a logical file name - length is not important 
65 OPEN "SFF MICROB SURGDVT" AS $FILES(l9); 
66 
67 ! opening my output file 
68 ! this is a physical file name and must be 24 characters long 
69 OPEN "$DA T A2 RP A TTE ROBOUT " AS $FILES(20); 
70 
71 ! selecting the date of surgery 
72 WRITE FORMAT ("SEARCH PATINTS FOR WHAT DATE? mnlldd/yy") 
73 INPUT"TIME (DUMMY $NOW); 
74 S"DATE:= WRITE $TIMETODATE (DUMMY) FORMAT (B2); 
75 ! P"NUM:= WRITE 00000001 FORMAT (B4); 
76 ! KEYON $FILES(l9) USING P"NUM APPROXIMATE; 
77 
78 ! the infamous keyon command 
79 KEYON $FILES(18) USING S"DATE GENERIC; 
80 WHILE RECORDIN $FILES( 18) DO 
81 
82 ! the patient's name, date of surgery, and O.R. room are extracted 
83 BEGIN ! beginning of the loop 
84 EXTRACT OR"ROOM FIRST 7 LENGTH 1; 
85 EXTRACT$PATIENT FIRST 14 LENGTH 4; 
86 EXTRACT PNAME FIRST 18 LENGTH 30; 
87 EXTRACT PROC"TEXT FIRST 58 LENGTH 60; 
















































KEYON $FILES( 19) USING SI\DA TE GENERIC ALTKEY "DT"; 
WHILE RECORDIN $FILES(19) DO BEGIN 
EXTRACT P A TIENTI\NUM FIRST 0 LENGTH 4, 
DATE FIRST 4 LENGTH 2; 
IF $PA TIENT = PA TIENTI\NUM AND $ASC(ORI\ROOM) <> 23 AND 
$ASC (0) END; 
IF FOUND THEN 
BEGIN 
jl\TIME := $DA TETOTIME (DATE); 
WRITE !FILES(20)! jI\TIME, $PATIENT, PNAME, $ASC(ORI\ROOM) 
$ASC (PROCI\CODE[5]) 
FORMAT (T(MTH "I" DAY "I" YR) "" F9 "" A20 "" F2 "" 
" " , " , , " , 
A30 "" F2 "" "" F3 1 I)' , , , ,., , ,
! checking for chemoprophylaxis using PTXT codes 
100 
BUILD CHEMOPROPHYLAXIS FROM $NOW BACK TO ($NOW -7 DAYS); 
FOR ONE :=1 TO $COUNT (CHEMOPRPHYLAXIS) DO 
BEGIN 
WRITE !CHEMOPROPHYLAXIS [ONE]. COUMADIN! FORMAT (!P40!) 
END; 
! writing the results to a file 
IF $EXISTS (CHEMOPROPHYLAXIS) THEN 
WRITE $FILES(20) ]I\TIME, $PATIENT, PNAME,$ASC(ORI\ROOM) 
$ASC(PROCI\CODE[5]) 
FORMAT (T(MTH "I" DAY "I" YR) "" F9 "" A20 "" F2 "" '" " , , , , , , , , 
A30 """ F2 "" "" F3)' , , , ,., , 
ELSE 
WRITE $FILES(20) ]I\TIME, $PATIENT, PNAME,$ASC(ORI\ROOM) 
$ASC(PROCI\CODE[ 5]) 
FORMAT (T(MTH "I" DAY "I" YR) "" F9 "" A20 "" F2 "" '" " , , , , , , , , 
A30 "" F2 "" "" F3)' , , , ,., , 
END; !IF FOUND 
! to avoid hogging the computer 
SLEEP (50); 
END; !WHILE RECORDIN $FILES(18) 
101 
135 ! closing the output files 
136 CLOSE $FILES(20); 
137 
138 ! closing the surgical patient files 
139 CLOSE $FILES( 19); 
140 CLOSE %FILES( 18); 
141 END; !MAIN 
142 END; !DVT 
APPENDIX] 
REPORT GENERATED BY PAL PROGRAM 
FOR CHEMOPROPHYLAXIS 
103 
An example of the report which gathered data on anti-coagulation for surgery patients in 
the DVT prophylaxis study. The data is real; all patient names have been replaced in 
order to protect patient confidentiality. The first column is the date, the second is the 
encounter number, the third is the patient's name. The next column is the OR theater 
number. The YeslNo indicates whether or not the patient had chemoprophylaxis 
(anticoagulation). The next column has the text description of the operation. The last 
column has the PTXT procedure code for the operation. 
January 29 1998 
01129/98 18272112 PATIENT, NAME 18 No EXPLORATORY LAPAROTOMY;ILEOSTO 14.24 
01/29/98 18271270 PATIENT, NAME 8 No LAP CHOLE W/GRAMS (C-ARM) 14.180 
01129/98 18269639 PATIENT, NAME 12 No LAP CHOLE WIG RAMS (C-ARM) SS E 14.180 
01129/98 18268979 PATIENT, NAME 18 Yes GBP 14.78 
01129/98 18267500 PATIENT, NAME 6 No LAP CHOLE W/GRAMS (C-ARM) 14.180 
01129/98 18187385 PATIENT, NAME 11 No LAP CHOLE WIG RAMS (C-ARM) 14.180 
01/29/98 18253922 PATIENT, NAME 11 No LAPAROSCOPIC COLECTOMY/CHOLE W 14.191 
01129/98 27925643 PATIENT, NAME 11 No LAP LYSIS ADHESIONS (BOWEL OBS 14.181 
01/29/98 28216356 PATIENT, NAME 12 No LAPAROTOMYI L COLECTOMY 14.24 
01129/98 28198083 PATIENT, NAME 9 No TAHJBSO 15.39 
01129/98 28196830 PATIENT, NAME 12 No EXC VAG MASS 15.43 
01129/98 28195923 PATIENT, NAME 7 No OPEN CHOLE 14.114 
01129/98 18243543 PATIENT, NAME 18 Yes GBP/FUNDOPLICATION 14.78 
01129/98 28157691 PATIENT, NAME 11 No LAP CHOLE W/GRAMS (C-ARM) 14.180 
01129/98 28166551 PATIENT, NAME 11 No LAP CHOLE 1 GRAMS ] 4.180 
01/29/98 18211672 PATIENT, NAME 11 No LAP CHOLE W/GRAMS (C-ARM) 14.180 
01129/98 18206490 PATIENT, NAME 12 No POST REP/ENTEROCELE REP/VAG SU 15.46 
01129/98 28119824 PATIENT, NAME 12 No TAH/BSO/MMKJSUPRA PUBIC CATH 15.40 
01129/98 18047621 PATIENT, NAME 12 No EXC VAG MASS 15.43 
APPENDIXK 
DAIL Y ENUMERATION OF CASES IN STUDY, 
NOVEMBER 1997 TO JANUARY 1998. 









































remind add-on SCD anti- both neither no mislabel 
er coag label 
24 3 22 5 0 0 0 0 
IS 4 19 0 0 0 0 0 
15 3 14 3 0 0 0 1 
14 0 14 0 1 0 1 0 
18 0 12 3 0 0 0 3 
3 0 3 0 0 0 0 0 
0 1 1 0 0 0 0 0 
30 1 21 to 0 0 1 1 
11 3 13 1 0 0 0 0 
16 1 to 6 0 0 0 1 
9 I 10 0 0 0 0 0 
19 4 19 2 2 0 0 0 
1 I 2 0 0 0 0 0 
0 0 0 0 0 0 0 0 
26 4 16 10 0 2 0 2 
21 1 21 0 0 0 0 1 
15 I 7 8 0 0 0 1 
12 0 13 0 0 0 1 0 
21 I 16 2 3 0 0 1 
0 I 1 0 0 0 0 0 
I 3 3 0 1 0 0 0 
23 2 19 3 0 0 0 3 
8 6 13 1 0 0 0 0 
1 3 4 0 0 0 0 0 
0 1 0 1 0 0 0 0 
8 0 8 0 0 0 0 0 
0 1 1 0 0 0 0 0 
3 I 3 1 0 0 0 0 
314 47 285 56 7 2 3 14 
number of eligible cases for that day 
number of cases which had the DVT reminder on the OR schedule 
number of cases added on, no DVT reminder on OR schedule 
number of cases which received compression devices 
number of cases which received anticoagulation 
cases with both compression devices and anticoagulation 
number of cases which received no DVT prophylaxis 
scheduled eligible cases which did not have a DVT reminder 
cases not in the study which incorrectly had a DVT reminder 
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remind add-on SCD anti- both neither no mislabel 
er coag label 
26 1 19 8 a a a a 
la I II a a a a a 
12 1 8 4 1 a a a 
14 5 17 2 a a a a 
14 1 13 a 1 a a 1 
I a 1 a a a a a 
a I 1 a a a a a 
27 I 19 7 2 a a a 
19 3 16 a 4 a a 2 
18 3 9 9 1 a a 2 
16 1 13 a 2 a a 2 
13 3 13 a 3 a 1 1 
I .., 4 a a a a a ..> 
a I 1 a a a a a 
33 2 28 4 a a a 3 
10 2 1 I a 1 1 I a 
la 1 7 3 a a a 1 
18 3 17 2 1 a a 1 
24 I 16 2 3 a a 4 
3 a 3 a a a a a 
a a a a a a a a 
18 1 17 1 a a a 1 
9 a 7 1 a a a 1 
4 3 5 1 a a a I 
2 a a a a 1 a I 
4 3 4 3 1 a 1 a 
1 4 5 a a a a a 
1 a a a 1 a a a 
29 1 22 6 1 a 1 2 
12 3 13 1 a a a 1 
10 1 8 1 1 a a I 
359 50 3a8 55 23 2 4 25 
number of eligible cases for that day 
number of cases which had the DVT reminder on the OR schedule 
number of cases added on, no DVT reminder on OR schedule 
number of cases which received compression devices 
number of cases which received anticoagulation 
cases with both compression devices and anticoagulation 
number of cases which received no DVT prophylaxis 
scheduled eligible cases which did not have a DVT reminder 
cases not in the study which incorrectly had a DVT reminder 
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remind add-on SCD anti- both neither no mislabel 
er coa~ label 
I I 2 0 0 0 0 0 
6 2 4 I 2 0 0 1 
I 3 3 0 0 0 0 1 
2 2 3 1 0 0 0 0 
19 2 14 6 0 0 0 I 
6 2 5 3 0 0 0 0 
13 I 6 8 I 0 I 0 
20 0 17 0 I 0 0 2 
21 2 17 3 2 0 0 1 
1 2 3 0 0 0 0 0 
0 1 I 0 0 0 0 0 
28 5 18 12 1 0 0 2 
10 6 IS 2 0 0 1 0 
20 4 12 9 0 0 0 3 
13 3 12 0 3 0 0 I 
18 0 13 0 1 0 0 4 
I 3 2 0 1 0 0 1 
0 I I 0 0 0 0 0 
28 2 23 4 2 0 1 2 
12 1 11 1 0 0 0 1 
24 2 10 10 0 1 0 5 
8 2 7 1 1 1 0 0 
14 1 15 1 0 0 I 0 
0 1 1 0 0 0 0 0 
0 2 2 0 0 0 0 0 
20 1 12 4 1 0 0 4 
17 0 14 2 0 0 I 2 
16 4 12 6 1 0 0 1 
19 2 18 0 0 1 1 3 
16 4 16 1 I 0 0 2 
0 3 2 0 0 1 0 0 
354 65 291 75 18 4 6 37 
number of eligible cases for that day 
number of cases which had the DVT reminder on the OR schedule 
number of cases added on, no DVT reminder on OR schedule 
number of cases which received compression devices 
nurrlber of cases which received anticoagulation 
cases with both compression devices and anticoagulation 
nurrlber of cases which received no DVT prophylaxis 
scheduled eligible cases which did not have a DVT reminder 
cases not in the study which incorrectly had a DVT reminder 
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remind add-on SCD anti- both neither no mislabel 
er coag label 
1027 162 884 186 48 8 13 76 
number of eligible cases for that day 
number of cases which had the DVT reminder on the OR schedule 
number of cases added on, no DVT reminder on OR schedule 
number of cases which received compression devices 
number of cases which received anticoagulation 
cases with both compression devices and anticoagulation 
number of cases which received no DVT prophylaxis 
scheduled eligible cases which did not have a DVT reminder 
cases not in the study which incorrectly had a DVT reminder 
108 
APPENDIXL 
SUMMARY BY PROCEDURE OF CASES IN STUDY 
Table 37. Number of cases and rate of prophylaxis by procedure for the study group in 
the Division of General Surgery. 
General Surgery Procedure 97 cases 97 proph percent 
abdominal perineal resection 3 3 100.0% 
anterior resection 4 4 100.0% 
axillery node dissection 10 10 100.0% 
bowel resection et al 42 42 100.0% 
open cholecystectomy 6 6 100.0% 
colectomy, right hemi 7 7 100.0% 
exploratory laparotomy 78 77 98.7% 
gastric resection 5 5 100.0% 
incisional hernia repair 12 12 100.0% 
mastectomy, uni,bi 10 10 100.0% 
modified radical mastectomy 21 21 100.0% 
neck dissection for removal of salivary gland 2 2 100.0% 
Nissen fundojJlication 3 3 100.0% 
parathyroidectomy 6 6 100.0% 
parotidectomy 2 2 100.0% 
radical groin dissection 3 3 100.0% 
radical neck dissection 4 4 100.0% 
sigmoid resection 3 3 100.0% 
splenectomy 5 5 100.0% 
subtotal thyroidectomy 1 I 100.0% 
thyroidectomy ]8 18 100.0% 
v~otomy 2 2 100.0% 
ventral hernia repair 35 35 100.0% 
gastric bypass 14 14 100.0% 
cho lecystojej unostomy 2 2 100.0% 
adrenalectomy 2 2 100.0% 
hemi-pelvectomy 1 1 100.0% 
Whipple 2 2 100.0% 
left colectomy 3 3 ]00.0% 
gastric bypass 7 7 100.0% 
pancreatectomy 5 5 100.0% 
closure colostomy 6 6 100.0% 
hepatectomy 8 8 100.0% 
esophago-gastrectomy - abd approach 4 4 100.0% 
spleno-renal shunt 2 2 100.0% 
pancreatic debridement 6 6 100.0% 
abdominal debridement 1 I 100.0% 
laparoscopic cholecystectomy, possible open 168 168 ]00.0% 
laparoscopic splenectomy 1 I 100.0% 
laparoscopic appendectomy 39 39 100.0% 
laparoscopic hernia repair 47 47 100.0% 
laparoscopic Nissen fundoplication 23 23 100.0% 
laparoscopic colon resection 4 4 100.0% 
total for General Surgery 627 626 99.8% 
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Table 38. Number of cases and rate of prophylaxis by procedure for the study group in 
the Division of Orthopedic Surgery. 
Orthopedic Surgery Procedure 97 cases 97 pro ph percent 
ankle fusion 11 11 100.0% 
sliding nail / DHS hip pinning 18 16 88.9% 
Kuntshcner nailing (1M rodding) 7 7 100.0% 
Thompson! Austin-Moore hip 3 3 100.0% 
total hip 65 65 100.0% 
total hip - revision 12 12 100.0% 
total knee 85 84 98.8% 
triple arthrodesis I I 100.0% 
ORIF femur II II 100.0% 
ORIF acetabulum 4 4 100.0% 
ORIF tibia 13 12 92.3% 
ORIF - tibia plateau I I 100.0% 
1M nailing tibia 2 2 100.0% 
total knee - revision 2 2 100.0% 
Thompson Austin Moore endoprosthesis I 1 100.0% 
total for Orthopedic Surgery 236 232 98.3% 
Table 39. Number of cases and rate of prophylaxis by procedure for the study group in 
the Division of Gynecologic Surgery. 
Procedure 97 cases 97 proph percent 
laparotomy, BSO, incidental appendectomy 5 5 100.0% 
laparotomy, ovarian cystectomy 2 0 0.0% 
rectocele repair I I 100.0% 
Marshal Marchetti 9 9 100.0% 
radical hysterectomy 2 2 100.0% 
radical vulvectomy 2 2 100.0% 
repair of cystocele 2 2 100.0% 
repair of cystocele and rectocele 7 7 100.0% 
total abdominal hysterectomy 88 88 100.0% 
vaginal hysterectomy 55 54 98.2% 
vaginal vault suspension, vaginally 2 2 100.0% 
plain vulvectomy 2 2 100.0% 
Burch urethropexy 5 5 100.0% 
vaginal vault suspension ... 3 100.0% .J 
laparoscopic assisted vaginal hysterectomy 30 30 100.0% 
lymph node dissection 12 12 100.0% 
total for Gynecologic Surgery 227 224 98.7% 
III 
Table 40. Number of cases and rate of prophylaxis by procedure for the study group in 
the Division of Urologic Surgery. 
Procedure 97 cases 97 proph percent 
nephrectomy 5 5 100.0% 
radical cystectomy with ilio conduit 2 2 100.0% 
retro·pubic prostatectomy 4 4 100.0% 
ureterop lasty 1 1 100.0% 
radical prostectomy, all types 24 24 100.0% 
pubo-vaginaJ sling 1 I 100.0% 
total for Urologic Surgery 36 36 100.0% 
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Table 41. Number of cases and rate of prophylaxis by procedure for the study group for 
all 4 Divisions. 
Division 97 cases 97 proph percent 
General Surgery 627 626 99.8% 
Orthopedic Surgery 236 232 98.3% 
Gynecologic Surgery 227 224 98.7% 
Urologic Surgery 36 36 100% 
Total 1126 1118 99.3% 
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